On this page
Quick Reference
Overview and Recommendations
Background
- •Define deep vein thrombosis as the presence of a thrombus in the deep veins, which are surrounded by muscle and carry the majority of venous return, as opposed to superficial veins. DVT and are considered two manifestations of the same disease process, VTE, sharing the same risk factors and management principles.
- •Classify DVT by anatomical location into proximal and distal (isolated calf) variants. Proximal DVT involves the popliteal, femoral, or iliac veins and carries a much higher risk of PE and PTS, whereas distal DVT is confined to the calf veins (posterior tibial, anterior tibial, and peroneal) and has a lower, though non-zero, risk of propagation.
- •Understand the etiologic distinction between provoked and unprovoked DVT to guide the duration of therapy. Provoked DVT occurs in the setting of transient risk factors like major surgery, trauma, or immobilization, while unprovoked DVT occurs without an obvious trigger and suggests a higher baseline risk of recurrence.
- •Recognize the role of Virchow’s Triad—venous stasis, endothelial injury, and hypercoagulability—in the pathogenesis of clot formation. Common triggers include malignancy, pregnancy, hormonal therapy, and inherited thrombophilias such as Factor V Leiden.
- •Identify life-threatening variants such as phlegmasia cerulea dolens, which is characterized by massive venous occlusion leading to limb cyanosis and potential arterial compromise. This is a surgical emergency that requires aggressive intervention to prevent gangrene and limb loss.
Evaluation
- •Suspect DVT in any patient presenting with unilateral leg pain, swelling, warmth, or erythema. While these signs are non-specific, the presence of a 'heavy' sensation in the limb or pain that worsens with weight-bearing should increase clinical suspicion.
- •Perform a focused physical examination comparing the affected limb to the contralateral side. Measure the calf circumference 10 cm below the tibial tuberosity; a difference of >3 cm is a significant predictor of DVT.
- •Assess for pitting edema and the presence of prominent, non-varicose collateral superficial veins. Palpate along the course of the deep veins to identify localized tenderness, particularly in the popliteal fossa or along the medial thigh.
- •Calculate the Wells Score for DVT to categorize the patient’s pre-test probability as low (0 points), moderate (1-2 points), or high (≥3 points). This score includes factors such as active cancer, recent immobilization, and the absence of a more likely alternative diagnosis.
- •Order a high-sensitivity D-dimer test for patients with a low or moderate pre-test probability. A negative D-dimer (<500 ng/mL or age-adjusted threshold) effectively rules out DVT in these groups without the need for imaging.
- •Apply age-adjusted D-dimer thresholds for patients over 50 years old to improve specificity. The formula is age × 10 µg/L (e.g., a 70-year-old has a cutoff of 700 µg/L).
- •Obtain a compression ultrasonography (CUS) as the first-line imaging study for patients with a high Wells score or a positive D-dimer. The diagnostic hallmark is the non-compressibility of a venous segment under the ultrasound probe.
- •Utilize whole-leg ultrasound if there is high suspicion of distal (calf) DVT, though many protocols focus on proximal CUS (groin to popliteal) due to the higher clinical significance of proximal clots.
- •Consider CT or MR venography for suspected DVT in atypical locations, such as the iliac veins, vena cava, or upper extremities, especially when CUS is inconclusive or technically limited by body habitus.
- •Rule out common mimics such as , ruptured Baker’s cyst (popliteal cyst), muscle tear (e.g., 'tennis leg'), or lymphedema. Cellulitis typically presents with higher fever and more diffuse erythema, while a ruptured cyst often shows a 'crescent sign' of bruising near the malleolus.
- •Screen for underlying malignancy in patients with a first-time unprovoked DVT. This should generally be limited to age-appropriate cancer screening (e.g., colonoscopy, mammography) rather than extensive 'fishing' with whole-body CT scans unless symptoms suggest a specific primary site.
Management
- •Initiate anticoagulation immediately upon diagnostic confirmation, or even prior to imaging if suspicion is high and the bleeding risk is low. The primary goal is to prevent thrombus propagation and embolization.
- •Administer direct oral anticoagulants (DOACs) as first-line therapy for most non-pregnant patients. Apixaban is dosed at 10 mg BID for 7 days followed by 5 mg BID; Rivaroxaban is dosed at 15 mg BID for 21 days followed by 20 mg daily.
- •Utilize Low-Molecular-Weight Heparin (LMWH), such as Enoxaparin 1 mg/kg every 12 hours, as the preferred agent for patients with active malignancy or those who are pregnant. LMWH is also used as a bridge for patients starting Warfarin.
- •Prescribe Warfarin for patients with severe renal failure (CrCl <15 mL/min) or (APS). Target an International Normalized Ratio (INR) of 2.0–3.0, maintaining LMWH bridging until the INR is therapeutic for at least 24 hours.
- •Treat provoked DVT (e.g., post-surgery) for a fixed duration of 3 months. Extending therapy beyond 3 months in these cases increases bleeding risk without significantly reducing recurrence.
- •Consider indefinite anticoagulation for patients with unprovoked DVT or persistent risk factors like active cancer, provided the bleeding risk is acceptable. Re-evaluate the risk-benefit ratio annually.
- •Avoid the routine use of Inferior Vena Cava (IVC) filters. These should be reserved strictly for patients with proven acute proximal DVT who have an absolute contraindication to anticoagulation (e.g., active intracranial hemorrhage).
- •Refer patients with phlegmasia cerulea dolens or massive iliofemoral DVT with impending limb ischemia for catheter-directed thrombolysis or surgical thrombectomy. These interventions are not indicated for routine DVT.
- •Encourage early ambulation as soon as therapeutic anticoagulation is achieved. Bed rest does not reduce the risk of PE and may actually promote further stasis and clot propagation.
- •Prescribe graduated compression stockings (30–40 mmHg) for symptomatic relief of edema, though they are no longer routinely recommended solely for the prevention of post-thrombotic syndrome based on recent trial data.
- •Monitor for treatment-related bleeding. Educate patients on signs of hemorrhage and the importance of medication adherence. For patients on DOACs, routine coagulation monitoring (PT/INR) is not required.
- •Manage isolated distal (calf) DVT with either 3 months of anticoagulation or serial ultrasound monitoring over 2 weeks. Anticoagulation is preferred if the patient is severely symptomatic or has high-risk features for propagation.
- •Evaluate for May-Thurner Syndrome in young patients, particularly women, presenting with left-sided iliofemoral DVT. This involves compression of the left common iliac vein by the right common iliac artery and may require stenting after initial anticoagulation.
Board Review — High Yield
- •Wells Score — A score of ≥3 indicates high probability; <2 with a negative D-dimer rules out DVT.
- •Age-adjusted D-dimer — Use (Age x 10) ng/mL for patients >50 years to reduce false positives.
- •Phlegmasia cerulea dolens — Massive venous congestion causing a cyanotic, painful, swollen limb; high risk of gangrene.
- •May-Thurner Syndrome — Compression of the left common iliac vein by the right common iliac artery; suspect in young females with left-leg DVT.
- •Paget-Schroetter Syndrome — Upper extremity DVT caused by repetitive overhead activity (effort thrombosis).
- •Post-thrombotic Syndrome (PTS) — Chronic complication featuring edema, skin hyperpigmentation, and ulcers due to venous valve damage.
- •Trousseau Syndrome — Migratory superficial thrombophlebitis associated with visceral malignancy (especially pancreatic cancer).
- •Factor V Leiden — The most common inherited thrombophilia; caused by resistance to activated protein C.
Deep Dive — Evidence Details
Definition, Synonyms, and Classification of Deep Vein Thrombosis
- ▸DVT is classified as proximal if it involves the popliteal vein or higher, which carries a significantly higher risk of pulmonary embolism compared to distal (calf) DVT [3].
- ▸The distinction between provoked and unprovoked DVT is the primary determinant for the duration of anticoagulation therapy [3].
- ▸Phlegmasia cerulea dolens represents the 'nadir' or peak clinical severity of DVT, characterized by total venous occlusion and potential limb-threatening ischemia [7].
Deep vein thrombosis (DVT) is defined as the formation of a blood clot (thrombus) within the deep venous system, most commonly occurring in the lower extremities, which results in partial or total occlusion of venous blood flow and carries a significant risk of pulmonary embolism (PE) [3]D. DVT and PE are collectively referred to under the umbrella term venous thromboembolism (VTE), representing two manifestations of the same underlying pathological process [3]D. The clinical significance of DVT lies in its potential for acute life-threatening complications and long-term morbidity, such as chronic and post-thrombotic syndrome (PTS) [1].
Synonyms and Alternate Nomenclature
In clinical practice and medical literature, DVT may be referred to by several synonyms depending on the context of the vessel involved or the underlying etiology. Common alternate names include:
- Deep Venous Thrombosis: An interchangeable term for DVT.
- Venous Thrombosis (VT): A broader term that may include both superficial and deep systems [13]D.
- Phlebothrombosis: A term emphasizing the formation of a clot without primary inflammation of the vein wall.
- Thrombophlebitis: Often used when the thrombus is associated with significant inflammation, though this more frequently refers to the superficial system.
- Portal Vein Thrombosis (PVT): A specific variant involving the portal venous system, often categorized separately due to its unique association with cirrhosis or non-cirrhotic [5]D[6]D.
- Lemierre's Syndrome: A specific form of septic internal jugular vein thrombosis typically caused by anaerobic oropharyngeal infections [9]C.
Temporal Phases and Stages of DVT
Understanding the temporal evolution of a thrombus is critical for determining the urgency of intervention and the duration of anticoagulation. While terms like "nadir" and "plateau" are more common in neurological literature, they are applied here to describe the clinical trajectory of venous obstruction and recovery [11]D.
- Prodromal Phase: The initial period of hypercoagulability or endothelial injury where a thrombus begins to form. Symptoms are often absent or minimal, consisting of vague limb heaviness or mild aching.
- Progressive Phase: The stage of active thrombus propagation. Without intervention, the clot may extend proximally (e.g., from the calf to the popliteal or femoral veins), increasing the risk of embolization [3]D.
- Nadir (Peak Severity): The point of maximal venous outflow obstruction and inflammatory response. In severe cases, this manifests as phlegmasia cerulea dolens, where massive edema compromises arterial inflow [7]D.
- Plateau Phase: A period of stabilization where the thrombus is no longer actively extending, typically achieved within 24 to 48 hours of initiating therapeutic anticoagulation [3]D.
- Recovery and Recanalization: The chronic phase where the body's endogenous fibrinolytic system begins to break down the clot. This phase determines the development of chronic venous disorders; incomplete recanalization or valvular damage leads to PTS [1].
Anatomic and Etiologic Classification
DVT is classified primarily by its location and the presence of provoking factors, as these variables dictate the risk of recurrence and the intensity of [3]D.
Anatomic Classification: Proximal vs. Distal
The distinction between proximal and distal DVT is the most important anatomic division. Proximal DVT involves the popliteal, femoral, or iliac veins. It is clinically more significant because it is more strongly associated with PE and long-term PTS [3]D. Distal (Isolated Calf) DVT is confined to the infrapopliteal veins (posterior tibial, anterior tibial, and peroneal veins). While the risk of PE is lower in distal DVT, approximately 15% to 25% of untreated calf thrombi will propagate proximally [3]D.
Etiologic Classification: Provoked vs. Unprovoked
- Provoked DVT: Occurs in the presence of a known, identifiable risk factor. These are further divided into transient factors (e.g., surgery, trauma, or immobilization) and persistent factors (e.g., active malignancy) [3]D.
- Unprovoked (Idiopathic) DVT: Occurs in the absence of obvious environmental or clinical triggers. Patients with unprovoked DVT have a significantly higher risk of recurrence and often require extended or indefinite anticoagulation [3]D[13]D.
Specialized Variants and Nomenclature
Certain anatomical locations require specialized classification systems due to their unique clinical implications.
Portal Vein Thrombosis (PVT)
PVT is classified based on the presence of underlying liver disease. Cirrhotic PVT is a common complication of end-stage liver disease, whereas Non-cirrhotic PVT may occur as a primary vascular disorder or due to porto-sinusoidal vascular disease (PSVD) [6]D[14]D. Chronic PVT often leads to cavernous transformation, where a network of collateral vessels (portal cavernoma) forms to bypass the obstructed segment [5]D[8]D.
Upper Extremity DVT
Often associated with central venous catheters or anatomical abnormalities (e.g., Paget-Schroetter syndrome). Specific cases may be complicated by infection, such as axillary abscesses leading to localized venous thrombosis [10]C.
Classification Protocol: Staging the Thrombus
Step 1 → Identify Anatomical Extent: Use duplex ultrasound to determine if the thrombus is proximal (popliteal and above) or isolated distal (calf only) [3]D. Step 2 → Assess Provocation Status: Evaluate for transient risk factors (surgery within 3 months, immobilization >3 days) or persistent factors (cancer) to classify as provoked or unprovoked [3]D. Step 3 → Determine Clinical Severity: Screen for signs of phlegmasia (massive swelling, cyanosis) which indicates a surgical or interventional emergency [7]D. Step 4 → Evaluate for Chronic Sequelae: In follow-up, use the VEIN-TERM consensus to classify any resulting chronic venous disorders or PTS [1].
| Variant | Key Distinguishing Feature | Clinical Implication |
|---|---|---|
| Proximal DVT | Involves popliteal, femoral, or iliac veins | High risk of PE; requires mandatory anticoagulation [3]D |
| Distal DVT | Confined to infrapopliteal (calf) veins | Lower PE risk; may be managed with serial imaging or anticoagulation [3]D |
| Phlegmasia Alba Dolens | 'Milk leg'; massive edema with preserved arterial flow | Early stage of limb-threatening venous occlusion |
| Phlegmasia Cerulea Dolens | Cyanotic limb with compromised arterial inflow | Surgical emergency; high risk of gangrene and amputation [7]D |
| Portal Vein Thrombosis | Thrombus in the portal vein or its branches | Associated with cirrhosis, PSVD, and portal hypertension [6]D[14]D |
| Category | Definition | Examples |
|---|---|---|
| Transient Provoked | Temporary risk factor present within 3 months | Major surgery, trauma, pregnancy, oral contraceptives [3]D |
| Persistent Provoked | Ongoing risk factor that remains present | Active malignancy, chronic inflammatory states [3]D |
| Unprovoked | No identifiable environmental or clinical trigger | Genetic thrombophilia (e.g., Factor V Leiden), idiopathic [13]D |
Epidemiology and Risk Factors
- ▸Reported DVT incidence depends strongly on whether routine imaging detects asymptomatic events; postoperative ultrasound screening was used in shoulder arthroscopy, foot and ankle surgery, and CRS-HIPEC studies [200][204][205].
- ▸Major risk contexts include orthopaedic surgery, lower-extremity fracture, arthroplasty, postoperative immobilization, major oncologic surgery, intracerebral haemorrhage, critical illness, and venous catheterization [190][195][199][202][204][205][209].
- ▸In the RIDTS post-hoc analysis, recurrent VTE occurred in 61 of 398 patients (15.3%) after anticoagulation for isolated distal DVT; most recurrences were distal DVT [191].
- ▸Potentially relevant patient or treatment modifiers include advanced age, diabetes, obesity with contraceptive exposure, cancer therapy, inflammatory markers, upadacitinib, and post-COVID syndrome [193][195][196][197][198][199][206].
- ▸Early ambulation, ankle-pump exercise, and intermittent pneumatic compression are prevention-related factors that address postoperative venous stasis, but the cited studies do not establish a single universal prophylaxis strategy for all patients [190][192][203].
Overview
Deep vein thrombosis (DVT) is part of the venous thromboembolism (VTE) spectrum, together with pulmonary embolism (PE). Its observed epidemiology varies substantially according to the population studied, the timing of assessment, the use of routine imaging, and whether asymptomatic events are included. Prospective ultrasonographic screening after shoulder arthroscopy and routine duplex screening after foot and ankle surgery were specifically used to identify events that symptom-based surveillance may miss [200][205]C. Similarly, routine postoperative duplex assessment has been used after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC), a setting in which major surgery, malignancy, and prolonged recovery may coexist [204].
Patient-related risk factors
Advanced age is an important risk context because older adults undergoing total knee arthroplasty (TKA), distal femur fracture surgery, or other major orthopaedic procedures may experience reduced mobility and a greater burden of comorbidity [196][199]. Diabetes mellitus has been specifically evaluated as a modifier of short- and long-term postoperative complications in geriatric patients undergoing distal femur fracture surgery, although the supplied abstract does not provide a DVT-specific effect estimate [199].
Obesity and exogenous hormonal exposure may interact to increase thromboembolic risk. In a United States database cohort of 789,453 non-pregnant females aged 12–19 years, the combined effect of body mass index and contraceptive use on PE was examined; the supplied abstract does not report the final risk estimates [206]. These findings should therefore be interpreted as evidence that the combination warrants risk assessment, rather than as a quantitative estimate of DVT risk in adolescents [206].
Cancer and cancer-directed treatment are clinically relevant risk settings. CRS-HIPEC for appendiceal pseudomyxoma peritonei was investigated because major oncologic surgery may be accompanied by prolonged operative duration, extensive disease burden, transfusion, and postoperative immobility [204]. In breast cancer, a systematic review and meta-analysis assessed VTE associated with cyclin-dependent kinase 4/6 (CDK4/6) inhibitors combined with endocrine therapy in patients with hormone receptor-positive, HER2-negative, non-metastatic disease [197]. The available abstract confirms that VTE risk was the focus of the analysis but does not provide the pooled DVT estimate [197].
Inflammation may contribute to thrombus formation in patients with fractures. A retrospective cohort of 493 patients with distal femur fractures evaluated inflammatory blood markers to predict preoperative lower-extremity DVT, indicating that inflammatory laboratory abnormalities may help identify higher-risk patients before surgery [195]. The supplied abstract does not establish that any single marker is suitable for universal clinical use [195].
Procedure-, injury-, and immobility-related risk factors
Orthopaedic surgery is a major risk context for postoperative VTE, with risk influenced by the operation, patient characteristics, anaesthesia, duration of immobility, and prophylaxis strategy [190]. In shoulder arthroscopy, a prospective cohort of 282 patients underwent bilateral lower-extremity venous ultrasonography before surgery and on postoperative day 1 to determine the incidence of otherwise clinically occult VTE and identify independent risk factors [200]. Operative duration was specifically evaluated as a potential independent risk factor [200].
Lower-extremity fracture and arthroplasty procedures combine tissue injury with restricted mobility. Distal femur fracture patients were studied for preoperative DVT risk [195], while older adults undergoing TKA were evaluated in a nursing-pathway study that included postoperative complications and rehabilitation outcomes [196]. A separate retrospective cohort examined whether ambulation within 24 hours after primary TKA or total hip arthroplasty was associated with postoperative DVT and other outcomes [203]. Because the study was observational, the association between early ambulation and DVT cannot by itself prove causation [203].
Foot and ankle surgery followed by short-leg splint immobilization with restricted ankle motion for more than 2 weeks represents another clinically important risk setting. A comparative study evaluated aspirin, enoxaparin, and no pharmacologic prophylaxis, with routine duplex ultrasonography at 2 weeks after surgery regardless of symptoms [205]C. The study design highlights that immobilization and surveillance intensity can strongly affect reported DVT rates [205]C.
Major abdominal oncologic surgery may carry particularly high thromboembolic risk. In CRS-HIPEC for appendiceal-origin pseudomyxoma peritonei, DVT was assessed by routine duplex ultrasonography on postoperative day 10, whereas CTPA was performed in symptomatic patients to evaluate PE [204]. Operative duration, peritoneal cancer index, prior surgery, cryoprecipitate transfusion, and postoperative factors were among the variables considered in evaluating thromboembolic events [204].
Medical illness, devices, and medications
Spontaneous intracerebral haemorrhage is another high-risk inpatient setting in which DVT prediction models have been developed. A systematic review identified 19 prediction models across 15 studies and pooled reported area-under-the-curve values, while also assessing risk of bias and applicability with PROBAST [202]. These models may support risk stratification, but the review evaluates prediction performance rather than establishing a single universal causal risk factor [202].
Indwelling venous access may contribute to thrombosis risk in critically ill patients. A propensity-matched cohort compared peripherally inserted central catheters with centrally inserted central venous catheters under standardized insertion protocols, using symptomatic thrombosis and infection outcomes among the safety endpoints [209]. The supplied abstract does not report the comparative thrombosis estimate, so catheter type should be considered a potential risk modifier rather than assigned a definitive relative risk from this study [209].
Drug exposure may alter VTE risk. A meta-analysis evaluated non-fatal DVT, non-fatal PE, and concurrent PE-DVT among patients with rheumatoid arthritis receiving upadacitinib versus comparator treatments [193]. The available abstract establishes the clinical question but does not provide the pooled numerical results [193]. Post-COVID syndrome has likewise been examined in a systematic review and meta-analysis for the prevalence of thromboembolic events, reflecting concern that thromboembolic susceptibility may persist after acute infection [198]. The supplied abstract does not provide a DVT-specific pooled prevalence [198].
Recurrence and related venous disease
After anticoagulation for isolated distal DVT (IDDVT), recurrence remains clinically relevant. In a post-hoc analysis of the RIDTS randomized trial involving 398 patients without cancer, 61 (15.3%) experienced recurrent VTE after treatment; the median interval from anticoagulation cessation was 6.2 months [191]. Of recurrent events, 47 (77%) were recurrent IDDVT and 14 (23%) were proximal DVT or symptomatic PE; 39 (63.9%) were symptomatic and 22 (36.1%) were asymptomatic [191]. Lower-limb superficial vein thrombosis is also linked with VTE, and the METRO trial evaluated long-term secondary prevention after completion of 45 days of fondaparinux [194].
Prevention-related context
The orthopaedic evidence base includes evaluation of intermittent pneumatic compression compared with no prophylaxis, chemoprophylaxis, or combined regimens [190]. Ankle-pump exercise combined with anticoagulant therapy has also been systematically assessed as a strategy to improve lower-extremity venous return after surgery [192]. These studies concern prevention rather than baseline epidemiology, but they reinforce the importance of immobility and venous stasis as modifiable components of postoperative DVT risk [190][192].
| Risk context | Evidence example |
|---|---|
| Orthopaedic surgery and immobility | IPC, chemoprophylaxis, and combined prophylaxis have been compared in orthopaedic populations [190]. |
| Lower-extremity fracture | Preoperative DVT prediction was studied in 493 distal femur fracture patients using inflammatory markers [195]. |
| Foot and ankle immobilization | Patients had restricted ankle motion for >2 weeks and routine duplex screening at 2 weeks [205]C. |
| Major oncologic surgery | CRS-HIPEC patients underwent routine duplex screening on postoperative day 10 [204]. |
| Medical and device-related risk | DVT prediction models were reviewed in spontaneous intracerebral haemorrhage, and catheter-associated thrombosis was evaluated in critically ill patients [202][209]. |
| Medication and systemic disease | VTE was evaluated with upadacitinib, CDK4/6 inhibitors, and post-COVID syndrome [193][197][198]. |
Etiology and Triggering Factors
- ▸DVT reflects interacting venous stasis, hypercoagulability, and endothelial or vessel-wall injury, with inflammation and platelet biology contributing to thrombus formation.[46][70][210]
- ▸Disaster-associated DVT has been reported at **10%–30%**, often emerging **1–2 weeks** after major earthquakes.[45]
- ▸Symptomatic PICC-related large-vein thrombosis occurred in **8.4%** of **431** neurological ICU PICC placements.[68]
- ▸Cancer promotes thrombosis through compression, invasion, cytokine-driven hypercoagulability, and treatment-related exposures.[47][51]
- ▸Central venous catheters and ICU admission are major pediatric DVT risks; central lines were reported in **100%** of neonatal and **92%** of non-neonatal secondary pediatric upper-extremity DVT cases.[48][67]
- ▸Burns and major trauma can produce all components of Virchow’s triad, and immediate post-trauma pulmonary thrombi may occur even without prolonged immobility.[54][62]
Overview
Deep vein thrombosis (DVT) results from the interaction of three pathogenic processes: venous stasis, hypercoagulability, and endothelial or vessel-wall injury, commonly summarized as Virchow’s triad.[70]D[210] Contemporary evidence also emphasizes inflammation, platelet activation, immune–endothelial interactions, and coagulation amplification as integral components of venous thromboembolism (VTE) pathogenesis.[46]D The relative contribution of each component varies with the patient, anatomic site, and provoking exposure; thrombosis may occur when one major factor predominates or when several moderate risks converge.[69]D[211]
Venous stasis and altered flow
Stasis is promoted by immobility, hospitalization, critical illness, paralysis, prolonged travel or sheltering, postoperative recovery, limb dependency, and mechanical compression of venous outflow.[45]D[50]D[54]D Major disasters can combine prolonged sitting or lying, restricted ambulation, dehydration, psychological and physiologic stress, and limited access to medical care; after major Japanese earthquakes, reported DVT incidence has ranged from 10% to 30%, with many events developing 1–2 weeks after the disaster.[45]D The timing supports continued surveillance and preventive measures after the immediate event, rather than only during the initial evacuation period.[45]D
Prone positioning may add a procedure-related stasis component in critically ill patients with COVID-19-associated acute respiratory distress syndrome; a retrospective ultrasound-screening study specifically evaluated the duration of proning as a possible DVT risk factor in this setting.[63]D The observation was hypothesis-generating and should not be interpreted as proof of causation.[63]D Venous valves are important local sites of thrombus initiation because valve cusps create disturbed, low-flow microenvironments; experimental vein-chip work demonstrated distinct endothelial adaptation at venous cusps compared with regions of uniform flow.[64]D
Venous outflow obstruction is another local trigger. Proximal obstruction and chronic postphlebitic changes may coexist with clinically silent or remote DVT, particularly in patients undergoing treatment for symptomatic venous insufficiency.[65]D Tumors can compress or invade veins, producing stasis and local vessel injury; cancer-associated abdominal thrombosis may therefore occur in splanchnic, ovarian, renal, or other unusual venous territories.[47]D Inferior vena cava thrombosis is particularly associated with malignancy: malignancy was present in 39% of patients with inferior vena cava thrombosis versus 7.8% of matched patients with isolated lower-extremity DVT.[212]C
Endothelial and vessel-wall injury
Endothelial injury may result from surgery, trauma, burns, invasive vascular procedures, inflammation, or direct tumor invasion.[47]D[50]D[54]D Surgical contributors include intraoperative venous distension and microvascular endothelial damage, which can act alongside postoperative stasis and systemic hypercoagulability.[50]D Central venous and peripherally inserted central catheters provide a direct local trigger through endothelial trauma, foreign-surface exposure, altered flow, and catheter-associated obstruction.[48]D[68]D
In a neurological intensive-care cohort, symptomatic PICC-related large-vein thrombosis occurred in 8.4% of 431 PICC placements; the investigators evaluated patient, catheter, and clinical variables within a Virchow-triad framework.[68]D In critically ill children, central venous catheter placement and ICU admission were identified as the two most important risk factors for DVT, with newer risk factors likewise mapping to vessel injury, altered hemostasis, and hypercoagulability.[48]D In children with upper-extremity DVT, central lines were the dominant trigger in secondary disease, reported in 100% of neonates and 92% of non-neonates; primary pediatric upper-extremity DVT was predominantly effort-related (87%).[67]D
Hypercoagulability and systemic prothrombotic states
Hypercoagulability may be inherited or acquired. Recognized individual risks include previous VTE, advanced age, cancer, and genetic traits associated with increased coagulation.[50]D Thrombophilia can act systemically, whereas local vessel injury or stasis can determine where thrombosis develops; this distinction is particularly relevant to portal-vein thrombosis and Budd–Chiari syndrome.[69]D Coagulation activation is also linked to platelet recruitment, inflammatory signaling, endothelial activation, and immune-cell interactions; platelets contribute to thrombus initiation, propagation, resolution, and recurrence.[46]D
Malignancy is a major acquired prothrombotic state. Tumor cells and the tumor microenvironment may promote coagulation through cytokine release, direct vascular invasion, and compression, while cancer-related surgery, chemotherapy, radiotherapy, and indwelling catheters add further provoking factors.[47]D[51]D In breast cancer, reported thrombotic rates during adjuvant chemotherapy range from 3% to 8%, with higher rates in postmenopausal women and in patients receiving chemotherapy with tamoxifen; tamoxifen-associated thrombosis has been reported at approximately 0.9%, whereas aromatase inhibitors were not associated with an increased risk in the cited review.[51]D
Major acquired triggers and high-risk clinical settings
Major burns combine endothelial damage, marked inflammatory and coagulation responses, hypercoagulability, and stasis from immobility, procedures, and critical illness; hospitalized burn patients therefore meet all components of Virchow’s triad.[54]D Pediatric patients with major burns covering a large total body-surface area similarly fulfill the triad and are at increased DVT risk, although incidence estimates and prophylaxis practices remain heterogeneous.[66]D Trauma can precipitate thrombosis through tissue injury, endothelial disruption, inflammation, reduced mobility, and coagulation activation. Importantly, pulmonary thrombi have been detected unexpectedly on immediate post-trauma CT in otherwise healthy young war-injured patients, challenging the assumption that clinically important thrombi require prolonged immobility or pre-existing hypercoagulability.[62]D
Hospitalization, ICU admission, major surgery, cancer, burns, trauma, catheterization, immobility, and disaster exposure may overlap; risk assessment should therefore consider cumulative rather than isolated triggers.[48]D[50]D[54]D Clinical risk-assessment models incorporate combinations of surgical and patient-related factors, including prior thromboembolism, malignancy, age, and thrombophilic traits.[50]D
Site-specific and mechanistic considerations
The same systemic risk may produce different thrombotic patterns depending on local anatomy and flow. Proximal DVT is clinically important because proximal thrombi are more likely than distal thrombi to cause severe complications such as pulmonary thromboembolism.[211] Abdominal and hepatic venous thromboses may reflect tumor compression or invasion, systemic thrombophilia, cirrhosis, or other acquired disorders.[47]D[69]D Biological markers, including microRNAs and coagulation-related biomarkers, are being investigated because D-dimer alone has limited specificity and may be falsely positive.[49]D These emerging markers currently describe pathobiology and diagnostic research rather than established etiologic criteria.[49]D
Overall, DVT is best understood as a multifactorial inflammatory and thrombotic process in which stasis, endothelial injury, and hypercoagulability interact with platelets, immune pathways, venous-valve microanatomy, and patient-specific exposures.[46]D[64]D[70]D
| Mechanism | Representative triggers or settings |
|---|---|
| Venous stasis | Immobility, hospitalization, critical illness, prone positioning, disaster sheltering, postoperative recovery, venous-valve disturbed flow, and proximal venous obstruction.[45]D[50]D[63]D[64]D[65]D |
| Endothelial or vessel-wall injury | Surgery, trauma, burns, tumor invasion, PICCs, central venous catheters, and inflammatory endothelial activation.[47]D[48]D[50]D[54]D[68]D |
| Hypercoagulability | Malignancy, chemotherapy, tamoxifen, inherited thrombophilia, prior VTE, advanced age, inflammation, platelet activation, and critical illness.[46]D[47]D[50]D[51]D[69]D |
| Combined mechanisms | Major burns, trauma, ICU admission, cancer surgery, catheterization, and disaster exposure.[45]D[48]D[50]D[54]D[62]D |
Pathophysiology
- ▸DVT is a thromboinflammatory process involving stasis, endothelial dysfunction, coagulation, platelets, leukocytes, hypoxia, and impaired fibrinolysis. [74][96][223]
- ▸Immobility reduces venous return; ankle-pump exercise targets venous stasis, whereas anticoagulation primarily targets coagulation. [192][220]
- ▸Hypoxia can reprogram immune-cell behavior across thrombus initiation, formation, and resolution. [223]
- ▸NET formation and citrullinated histone H3 are associated with unfavorable clot characteristics and post-thrombotic syndrome. [77]
- ▸Monocyte/macrophage activity contributes to late venous-wall fibrosis, while macrophage modulation may enhance experimental thrombus resolution. [95][219]
- ▸Rheumatoid arthritis is associated with approximately 50–100% excess risk of DVT and pulmonary embolism, particularly during early disease and flares. [221]
Overview
Deep vein thrombosis (DVT) is best understood as a thromboinflammatory disorder rather than an isolated coagulation abnormality. Thrombus initiation, propagation, and resolution involve the interaction of venous blood flow, the vessel wall, coagulation and fibrinolytic systems, platelets, leukocytes, and local inflammatory signaling. [223]D The classic contributors remain venous stasis, endothelial or venous-wall activation/injury, and hypercoagulability; the supplied evidence particularly supports the importance of stasis, endothelial dysfunction, immune activation, impaired fibrinolysis, and hypoxia. [74][98]D[213][221]D[223]D
Venous stasis and altered flow
Reduced lower-extremity movement diminishes the skeletal-muscle pump and venous return, promoting blood pooling and local activation of coagulation. [192][220] This mechanism helps explain postoperative and hospital-acquired DVT, in which immobility, hospitalization, surgery, and other clinical stressors increase thrombotic risk. [76][192][213] Ankle-pump exercise is mechanistically complementary to anticoagulation because it enhances lower-extremity venous return, whereas anticoagulants do not directly correct venous stasis. [192] Prolonged screen-related sitting, described as “e-thrombosis,” represents a potential modern stasis exposure; in the reported adolescent cohort, thrombosis was associated with at least 4 hours of daily screen exposure, although this observational association does not establish causation. [215]C
Altered gravity can also modify venous flow. During parabolic-flight exposure, internal jugular-vein cross-sectional area increased during 0.00-G, 0.25-G, and 0.50-G conditions on the left and during 0.00-G and 0.25-G conditions on the right compared with seated preflight measurements, indicating gravity-dependent venous distension and altered flow that may contribute to venous thrombosis risk in weightlessness. [214]C Severe chest trauma may promote low-flow states through localized inflammation and occult vascular injury; these mechanisms have been proposed in relation to post-traumatic pulmonary embolism, although the study did not establish that pulmonary emboli originated from lower-extremity DVT. [98]D
Endothelial activation and coagulation imbalance
Endothelial dysfunction shifts the venous wall toward a prothrombotic phenotype by impairing endogenous anticoagulant and fibrinolytic protection while facilitating inflammatory and platelet interactions. [74][96]D[221]D SARS-CoV-2-associated vascular injury illustrates this mechanism: direct endothelial injury, pro-inflammatory cytokines, platelet activation, impaired fibrinolysis, elevated D-dimer, and fibrinogen dysregulation can persist in long COVID and contribute to hypercoagulability, microthrombosis, and venous thromboembolism. [74]
Endothelial cell-specific molecule-1 (ESM1), a proteoglycan secreted by endothelial cells, is being investigated as an endogenous anticoagulant and endothelial-protective factor. Circulating ESM1 was higher in individuals with VTE than in healthy controls (498.54 versus 198.68 pg/mL), and combining ESM1 with D-dimer improved diagnostic discrimination; experimental zebrafish, mouse, and in-vitro findings further supported an anticoagulant effect, including activation of an endogenous thrombin-inhibitory pathway. [96]D These findings suggest that altered endothelial anticoagulant capacity may participate in venous thrombosis, but they do not yet define ESM1 as a causal biomarker or treatment in human DVT. [96]D
Thromboinflammation, hypoxia, and NETs
Venous thrombus formation is coordinated by immune mechanisms collectively termed thromboinflammation. [223]D Stasis and reduced oxygen delivery create a hypoxic venous microenvironment, while intracellular metabolic reprogramming may produce “pseudohypoxia”; hypoxia can then reprogram immune-cell behavior throughout thrombus initiation, growth, and resolution. [223]D Chronic inflammatory disease can amplify this process. In rheumatoid arthritis, inflammatory cytokines, endothelial dysfunction, platelet activation, impaired fibrinolysis, and autoantibody-associated immune responses generate chronic immunothrombosis; population studies report approximately 50–100% excess risk of DVT and pulmonary embolism, with particularly high risk early after diagnosis and during flares. [221]D
Neutrophil extracellular traps (NETs) provide a structural and inflammatory link between innate immunity and coagulation. Increased NET formation is implicated in DVT pathogenesis, and higher citrullinated histone H3 was associated with an unfavorable fibrin-clot phenotype in patients with DVT. [77] In that cohort, H3cit, thrombin generation, clot permeability, clot-lysis time, and inflammatory markers were assessed after anticoagulation, and higher NET-related activity was studied in relation to later post-thrombotic syndrome (PTS). [77]
Thrombus resolution and post-thrombotic injury
Resolution requires coordinated fibrinolysis, leukocyte recruitment, macrophage activity, and remodeling of the thrombus and vein wall. [77][95]D[219][223]D Persistent inflammation and impaired thrombus resolution can leave venous obstruction, valvular damage, and fibrotic vein-wall remodeling, contributing to PTS. [77][219] Monocytes and macrophages are major cellular mediators of later thrombus organization and vein-wall healing; in mouse stasis and flow-restricted models, monocyte/macrophage depletion reduced late venous-wall fibrotic injury, supporting a causal role for these cells in post-thrombotic remodeling. [219]
Experimental evidence indicates that macrophage phenotype and hypoxia-linked signaling influence resolution. In mice with stasis-induced DVT, cyanidin-3-O-glucoside reduced thrombus weight, length, and cross-sectional area at 14 days, increased intrathrombotic CD68-positive macrophages, suppressed macrophage M1-associated inflammation, and attenuated HIF-1α-linked signaling. [95]D These findings are preclinical and should not be extrapolated to dietary or therapeutic use in humans. [95]D
Clinical contexts that reinforce the mechanism
The pathophysiological model explains why DVT risk rises after total hip arthroplasty, when surgery, tissue injury, inflammation, and reduced mobility coexist. [76][220] It also explains why prevention strategies that combine anticoagulation with restoration of venous flow, such as ankle-pump exercise and early mobilization, target complementary mechanisms. [192][220] Network meta-analysis evidence in THA has evaluated TCM decoctions through effects on coagulation and DVT outcomes, while pharmacokinetic work has characterized 39 compounds in Mailuoning oral liquid; these findings concern interventions rather than proof of the underlying causal pathway. [76][218] ADPKD-associated portal-vein and inferior-vena-cava thrombosis has likewise been examined in autopsy material, indicating that structural abdominal venous and disease-specific factors may influence thrombosis, although the small reported case series limits mechanistic generalization. [216]C
Overall, DVT develops when stasis and local hypoxia coincide with endothelial activation, coagulation and platelet activity, inflammatory-cell recruitment, NET formation, and insufficient fibrinolysis. The subsequent balance between thrombus organization, immune resolution, and vein-wall fibrosis determines whether venous patency is restored or PTS develops. [74][77][95]D[96]D[219][223]D
| Mechanism | Pathophysiological effect | Supporting evidence |
|---|---|---|
| Venous stasis | Reduced venous return and low-flow conditions favor thrombus formation | Postoperative immobility, hospital-acquired VTE, screen-related inactivity, and altered gravity [192][213][214]C[215]C |
| Endothelial dysfunction | Loss of anticoagulant protection with inflammatory and platelet activation | COVID-19/long COVID and ESM1 studies [74][96]D |
| Immunothrombosis | Cytokines, immune cells, platelets, and NETs amplify coagulation | RA and NET-related studies [77][221]D[223]D |
| Impaired resolution | Persistent thrombus and vein-wall inflammation promote fibrosis and PTS | Macrophage depletion and C3G mouse studies [95]D[219] |
Clinical Features
- ▸Physical examination findings like Homan's sign are unreliable; diagnosis must rely on validated clinical prediction rules like the Wells Score.
- ▸For patients over 50 years of age, the D-dimer threshold should be age-adjusted (age × 10 µg/L) to safely rule out DVT while minimizing over-imaging.
- ▸Obesity (BMI ≥30 kg/m²) significantly increases DVT risk and may alter the diagnostic utility of standard D-dimer cutoffs.
The clinical presentation of (DVT) is notoriously variable, often described as a "hidden" condition due to its non-specific signs that frequently overlap with other musculoskeletal or vascular pathologies [107][122]D. A clinician must maintain a high index of suspicion, particularly in patients with known risk factors such as recent orthopedic surgery [100][110], obesity [104][105], or malignancy [126]D. The diagnostic process begins with a structured history and physical examination to determine the pre-test probability, which then dictates the necessity of further imaging or laboratory testing [122]D[125]D.
Presenting Symptoms
Patients typically present with unilateral limb complaints that develop over hours to days. The most common symptom is calf pain or tenderness, often described as a dull ache or "cramping" sensation that worsens with weight-bearing [122]D. Swelling is the most reliable clinical sign, usually occurring distal to the site of the thrombus. In lower extremity DVT, this may involve the entire leg (iliofemoral DVT) or be localized to the calf (femoropopliteal or isolated calf DVT) [112].
In specific populations, symptoms may be more subtle. For instance, elderly patients may present with vague discomfort that is easily attributed to existing comorbidities like or ( ) [111][123]D. In children, chronic limb pain following a DVT may indicate the development of (PTS), which can occur with or without visible physical findings of chronic [101].
Physical Examination Findings
The physical examination should be systematic, comparing the affected limb to the contralateral side to identify subtle asymmetries.
- Inspection: Observe for unilateral edema, erythema, and prominent superficial collateral veins. In severe cases, the limb may appear cyanotic (phlegmasia cerulea dolens) or pale and waxy (phlegmasia alba dolens) due to massive venous obstruction and secondary arterial compromise [122]D.
- Palpation: Assess for localized tenderness along the distribution of the deep venous system. Increased skin temperature (warmth) is common but non-specific. Pitting edema should be documented by applying firm pressure over the medial malleolus or pretibial area for at least 5 seconds.
- Circumferential Measurements: Measure the calf circumference 10 cm below the tibial tuberosity. A difference of >3 cm between limbs is a significant predictor of DVT and is a core component of the Wells score [112][122]D.
- Maneuvers: While historically taught, Homan's sign (pain in the calf upon forced dorsiflexion of the foot) is neither sensitive nor specific and is no longer recommended as a primary diagnostic tool [122]D.
Clinical Prediction Rules
Because physical signs alone are unreliable, validated scoring systems like the Wells Score are essential to categorize patients into low, moderate, or high-probability groups. This stratification determines the utility of a D-dimer test versus immediate imaging [112][122]D.
| Clinical Feature | Points |
|---|---|
| Active cancer (treatment within 6 months or palliative) | +1 |
| Paralysis, paresis, or recent plaster immobilization of the lower extremity | +1 |
| Recently bedridden >3 days or major surgery within 12 weeks | +1 |
| Localized tenderness along the distribution of the deep venous system | +1 |
| Entire leg swollen | +1 |
| Calf swelling >3 cm compared to asymptomatic leg | +1 |
| Pitting edema confined to the symptomatic leg | +1 |
| Collateral superficial veins (non-varicose) | +1 |
| Previously documented DVT | +1 |
| Alternative diagnosis at least as likely as DVT | -2 |
Interpretation: 0 = Low probability; 1-2 = Moderate probability; ≥3 = High probability [112][122]D.
Step-by-Step Clinical Assessment Protocol
Step 1 → Identify Risk Factors: Screen for recent surgery (especially hip/knee arthroplasty [113][118]D), prolonged immobility, obesity (BMI ≥30 kg/m²) [105][117]D, or use of combined hormonal contraceptives [108]. Step 2 → Perform Targeted Exam: Measure calf circumferences and assess for pitting edema and localized tenderness [122]D. Step 3 → Calculate Wells Score: Determine pre-test probability to guide the next diagnostic step [112]. Step 4 → Apply Age-Adjusted Thresholds: For patients >50 years, use the age-adjusted D-dimer cutoff (age × 10 µg/L) to increase diagnostic specificity and reduce unnecessary imaging [102].
Phenotypic Variants
| Variant | Key Features | Frequency/Context |
|---|---|---|
| Upper Extremity DVT | Swelling and pain in the arm; often associated with central venous catheters or strenuous activity (Paget-Schroetter syndrome) [120]D. | 5-10% of all DVT cases |
| Pediatric DVT | Often secondary to central lines; high risk of PTS-related chronic pain [101][109]. | Rare; increasing in tertiary care |
| Pregnancy/Postpartum DVT | Increased risk due to hypercoagulability and venous stasis; often involves the left iliac vein due to May-Thurner anatomy [106][107]. | 1 in 1000 pregnancies |
| Obesity-Associated DVT | Higher baseline D-dimer levels may complicate diagnosis; increased risk in bariatric and cosmetic surgery populations [105][121]D[126]D. | Common in high-BMI cohorts |
Red Flags
Certain findings necessitate urgent intervention to prevent limb loss or fatal (PE):
- Respiratory Distress: Sudden onset dyspnea, tachypnea, or pleuritic chest pain suggests PE [106][109].
- Phlegmasia Cerulea Dolens: Massive edema, cyanosis, and severe pain indicating near-total venous occlusion; requires emergent vascular consultation [122]D.
- Neurological Deficit: While rare in isolated DVT, sudden weakness or sensory loss in the setting of suspected venous thrombosis may indicate (CVT), particularly in pregnant or postpartum patients [107][108].
Atypical Presentations
Clinicians should be wary of "masked" DVT. In patients with large uterine fibroids, pelvic venous stasis can lead to DVT without typical distal triggers [79]D. Furthermore, in the elderly, the prevalence of DVT is significantly higher (17.10%), yet symptoms are often attributed to general frailty or chronic venous insufficiency [111][115]D. In patients with COPD, an acute exacerbation may actually be triggered by an occult PE secondary to an asymptomatic DVT [123]D.
| Clinical Feature | Points |
|---|---|
| Active cancer | +1 |
| Paralysis or recent immobilization | +1 |
| Recent major surgery (<12 weeks) | +1 |
| Localized tenderness | +1 |
| Entire leg swollen | +1 |
| Calf swelling >3 cm (measured 10cm below tuberosity) | +1 |
| Pitting edema (symptomatic leg only) | +1 |
| Collateral superficial veins | +1 |
| Previous DVT | +1 |
| Alternative diagnosis as likely as DVT | -2 |
| Variant | Key Features | Context |
|---|---|---|
| Upper Extremity | Arm swelling, catheter-related | Central lines, Paget-Schroetter |
| Pediatric | Chronic pain, PTS risk | Central venous access |
| Pregnancy-related | Left-sided predominance | Hypercoagulability of pregnancy |
| Phlegmasia | Cyanosis, limb-threatening ischemia | Massive iliofemoral occlusion |
Diagnosis and Workup
- ▸Use objective venous ultrasonography to confirm suspected lower-extremity DVT, including consideration of distal calf-muscle thrombosis in high-risk or minimally symptomatic patients [228][240][242].
- ▸Postoperative D-dimer elevation is nonspecific after total hip or knee arthroplasty; an elevated result should not be treated as diagnostic without imaging [230].
- ▸Dynamic D-dimer trajectories and prediction models may support risk stratification but do not replace diagnostic imaging [202][231].
- ▸Risk-prediction tools developed in hip fracture, intracerebral hemorrhage, total knee arthroplasty, or hospitalized populations require external validation before general use [202][239][241][242][244].
- ▸Distinguish conventional DVT from venous tumor thrombus and pulmonary or portal vascular thrombosis [232][233][234][238].
Scope and clinical approach
Deep vein thrombosis (DVT) should be approached as a clinical diagnosis requiring objective venous imaging, with the diagnostic pathway adapted to the patient’s setting, timing, and pretest risk. The supplied evidence is dominated by postoperative, immobilized, neurologic, orthopedic, and hospitalized cohorts; therefore, study-specific prediction models should support rather than replace clinical assessment and imaging [202][228][231][239][241][242][244].
The initial assessment should document limb symptoms and signs, recent surgery or trauma, immobility, cancer, neurologic disease, prior thrombosis, and other recognized thrombotic-risk features. In elderly patients with hip fracture, preoperative isolated calf muscle vein thrombosis was specifically investigated because it is frequently asymptomatic and may be overlooked [242]. DVT may also occur despite prophylaxis: early postoperative DVT was studied after head-and-neck cancer free-flap reconstruction despite routine heparin prophylaxis [235]. After arthroscopic rotator-cuff repair, investigators prospectively assessed asymptomatic lower-extremity DVT using ultrasonography and perioperative D-dimer trends [240]C.
Laboratory testing
D-dimer is most useful as a rule-out test in an appropriate low-risk diagnostic context, but the supplied evidence emphasizes important limitations in postoperative patients. A 2026 meta-analysis evaluated D-dimer for DVT screening after total hip or knee arthroplasty and highlighted that surgical trauma causes nonspecific D-dimer elevation, making diagnostic accuracy controversial in this population [230]. Accordingly, an elevated postoperative D-dimer should not be interpreted as diagnostic of DVT and should generally prompt imaging rather than treatment based on the laboratory result alone [230].
Dynamic D-dimer information may improve risk stratification in selected high-risk populations. A multicenter retrospective study of patients undergoing emergency surgery for ruptured intracranial aneurysm developed and internally-external validated a nomogram using D-dimer trajectories and other predictors for postoperative lower-extremity DVT [231]. Similarly, risk-prediction research in spontaneous intracerebral hemorrhage identified multiple models, but the systematic review found heterogeneity in model development and performance, supporting cautious use pending external validation [202]. These tools are prediction instruments, not diagnostic substitutes for venous imaging [202][231].
Venous imaging
Compression venous ultrasonography is the principal objective test represented in the supplied evidence. In patients treated with intravenous thrombolysis for acute ischemic stroke, in-hospital lower-extremity DVT was confirmed by venous ultrasonography; early pharmacological prophylaxis was defined as initiation within 24–48 hours after thrombolysis once repeat neuroimaging excluded intracranial hemorrhage [228]. The same imaging approach was used to investigate DVT after arthroscopic rotator-cuff repair [240]C. In elderly hip-fracture patients, investigators specifically evaluated isolated calf-muscle venous thrombosis, underscoring the importance of considering distal disease when symptoms are absent or nonspecific [242].
When clinical suspicion persists despite an initially negative examination, the possibility of distal or evolving thrombosis should be considered, particularly in postoperative, immobilized, or high-risk patients; the supplied studies do not establish a single universal repeat-imaging interval [228][235][240]C[242]. Imaging reports should specify the involved venous segment and distinguish lower-extremity DVT from other thrombotic entities because the cited oncology studies concern venous tumor thrombus rather than conventional thrombus [232][234].
Risk-stratification and prediction models
Prediction models may help prioritize imaging in populations with substantial baseline risk. A machine-learning calculator was developed for preoperative DVT prediction in elderly hip-fracture patients using 18 clinical parameters, with temporal validation in a later cohort [239]. Another hospitalized-patient model used routinely available clinical and laboratory indicators and applied explainability methods to identify influential predictors; however, it was a retrospective single-center study with 159 DVT cases and 72 non-DVT cases [244]. After total knee arthroplasty, a multimodal deep-learning model combined early postoperative radiographs with electronic medical-record data; the cohort included 1,200 patients and reported an 18.0% DVT incidence, while the authors noted limited performance of conventional Caprini scoring in their setting [241]. A nomogram for elderly hip-fracture patients focused specifically on preoperative isolated calf-muscle thrombosis [242]. These models require local calibration and external validation before routine implementation [239][241][242][244].
Differential diagnosis and evidence boundaries
Pulmonary artery thrombosis in Behçet disease, venous tumor thrombus associated with renal-cell carcinoma, and portal-vein tumor thrombus in hepatocellular carcinoma are distinct conditions and should not be automatically classified as lower-extremity DVT [233]C[232][234][238]. Pediatric pulmonary-embolism exclusion research evaluated the PERC-Peds rule, not a lower-extremity DVT diagnostic pathway [237]. Studies of retinal vein occlusion, anti-VEGF therapy, post-thrombotic venous stenting, and nursing or intermittent pneumatic-compression prevention address different diseases or management questions and do not establish diagnostic criteria for acute DVT [226][227][229][243]C.
| Clinical context | Workup implication |
|---|---|
| Total hip or knee arthroplasty | Interpret D-dimer cautiously because surgical trauma can cause nonspecific elevation; use venous imaging for confirmation [230]. |
| Acute ischemic stroke after intravenous thrombolysis | Lower-extremity DVT was confirmed by venous ultrasonography; prophylaxis studies used a 24–48-hour post-thrombolysis window after repeat neuroimaging excluded hemorrhage [228]. |
| Ruptured intracranial aneurysm surgery | Dynamic D-dimer trajectories were incorporated into a predictive nomogram, but the model remains risk stratification rather than diagnosis [231]. |
| Elderly hip fracture | Consider preoperative and isolated calf-muscle thrombosis, including asymptomatic disease; prediction models may help prioritize assessment [239][242]. |
| Total knee arthroplasty or hospitalization | Machine-learning tools may assist risk estimation, but retrospective design and need for validation limit immediate clinical substitution for imaging [241][244]. |
Differential Diagnosis of Deep Vein Thrombosis
- ▸Vascular leiomyosarcoma should be suspected if an apparent DVT fails to respond to anticoagulation or shows interval growth on imaging [155, 161].
- ▸Cellulitis and DVT frequently coexist; age is a primary risk factor for this dual pathology [158].
- ▸Tennis leg (gastrocnemius tear) is the most common musculoskeletal mimic and is distinguished by the location of fluid collections on ultrasound [153].
The clinical presentation of deep vein thrombosis (DVT) is notoriously non-specific, often overlapping with a wide array of infectious, musculoskeletal, and neoplastic conditions. Because the sequelae of DVT—including and chronic venous —carry significant morbidity, clinicians must systematically exclude mimics while maintaining a high index of suspicion for concurrent pathologies [144]D. In many cases, conditions like or Charcot neuroarthropathy may not only mimic DVT but also serve as pro-inflammatory triggers for its development [154]D[158]D.
Infectious and Inflammatory Mimics
Cellulitis is the most frequent clinical mimic of DVT, characterized by erythema, warmth, and edema. However, the relationship is complex; the pro-inflammatory state induced by lower limb cellulitis significantly increases the risk of secondary DVT [158]D. Age is a critical risk factor, with older patients exhibiting a higher prevalence of concurrent DVT during cellulitis episodes [158]D.
Charcot Neuroarthropathy (CN), particularly in its acute phase, presents with a red, hot, swollen foot that is frequently misdiagnosed as DVT or cellulitis [154]D. This inflammatory condition affects patients with , often secondary to diabetes, and involves a cascade of inflammatory cytokines such as TNF-α, IL-1β, and IL-6 that drive bone resorption [154]D. Early identification is vital, as the 5-year mortality rate for CN is as high as 29.0% [147]D.
In the upper body, must be considered when internal jugular vein thrombosis occurs following acute pharyngitis or oropharyngeal infection [143]C[150]C. This condition, often associated with Streptococcus constellatus or Fusobacterium necrophorum, can lead to septic pulmonary emboli and pulmonary artery pseudoaneurysms [150]C[167]C.
Musculoskeletal and Soft Tissue Disorders
Tennis Leg refers to an acute rupture or strain of the posterior calf muscles, most commonly the medial of the gastrocnemius at the distal myotendinous junction [153]D. While it presents with sudden-onset pain and swelling similar to DVT, ultrasound can differentiate the two by identifying fluid collections between the gastrocnemius and soleus muscles rather than intraluminal thrombus [153]D.
Ruptured Baker’s Cyst ( ) can cause acute calf pain and swelling that mimics DVT. Similarly, Diabetic Myonecrosis is a rare but serious complication in patients with end-stage kidney disease (ESKD) that presents with ischemic muscle necrosis, often requiring MRI for differentiation from DVT or cellulitis [164]C.
Neoplastic and Rare Vascular Mimics
Primary Vascular Leiomyosarcoma (VLMS) is a rare, aggressive smooth muscle tumor that is frequently misdiagnosed as chronic DVT [148][155]C. A key clinical red flag is the persistence or progression of symptoms despite therapeutic anticoagulation [155]C[161]C. On imaging, VLMS often appears as an intensely FDG-avid intraluminal mass on PET/CT or shows peripheral enhancement on MRI, unlike the non-enhancing nature of a standard thrombus [161]C.
Intravascular Fasciitis (IVF) is a benign myofibroblastic proliferation that can mimic DVT, even in the setting of anatomical predispositions like May-Thurner Syndrome [157]C. Definitive diagnosis requires histopathology showing USP6 rearrangement via FISH [157]C.
Diagnostic Algorithm for Differentiation
Step 1: Clinical Risk Assessment
Evaluate for risk factors of DVT (immobilization, malignancy) versus mimics (diabetes for Charcot, recent infection for Lemierre, or trauma for Tennis Leg) [147]D[153]D[158]D.
Step 2: Initial Imaging (Duplex Ultrasound)
Assess for venous compressibility. If a mass is non-compressible but shows internal vascularity or atypical morphology, consider vascular tumors [148][155]C.
Step 3: Advanced Imaging for Atypical Cases
If symptoms persist despite anticoagulation, order Contrast-Enhanced CT or MRI. Look for "ring enhancement" or interval growth, which suggests leiomyosarcoma or organizing thrombus rather than acute DVT [155]C[156]C[163]C.
Step 4: Laboratory and Systemic Workup
In cases of suspected Lemierre syndrome, obtain blood cultures [150]C. For suspected Charcot, focus on inflammatory markers and metabolic balance [154]D.
Comparative Features of DVT and Mimics
| Condition | Key Differentiating Feature | Preferred Imaging | Clinical Context |
|---|---|---|---|
| Deep Vein Thrombosis | Non-compressible vein; no internal flow | Duplex Ultrasound | Post-op, immobility, cancer [144]D |
| Cellulitis | Diffuse erythema; skin warmth | Clinical / Ultrasound | Bacterial entry site; fever [158]D |
| Tennis Leg | Fluid at gastrocnemius-soleus interface | Ultrasound / MRI | Sudden "pop" during exercise [153]D |
| Leiomyosarcoma | Intraluminal mass growth on anticoagulation | MRI / PET-CT | Chronic, progressive swelling [155]C[161]C |
| Charcot Foot | Neuropathic joint destruction; midfoot collapse | X-ray / MRI | Diabetic with neuropathy [147]D[154]D |
| Lymphedema | Non-pitting edema; Stemmer sign | Clinical / Lymphoscintigraphy | Post-lymph node dissection [145]D |
| Feature | DVT | Cellulitis | Tennis Leg | Charcot Foot |
|---|---|---|---|---|
| Onset | Subacute | Acute/Subacute | Sudden/Traumatic | Subacute |
| Primary Site | Deep veins | Dermis/Soft tissue | Medial gastrocnemius | Midfoot/Ankle |
| Erythema | Possible (mild) | Intense/Diffuse | Rare | Intense |
| Imaging Finding | Intraluminal thrombus | Soft tissue edema | Myotendinous tear | Bone fragmentation |
| Key Risk Factor | Stasis/Hypercoagulability | Skin break | Athletics | Diabetes/Neuropathy |
Special Populations
- ▸Pediatric VTE follow-up for postthrombotic sequelae is necessary but internationally nonstandardized.[245]
- ▸Bland cancer-associated splanchnic thrombosis must be distinguished from tumor thrombus because the evidence and treatment objectives differ.[253,183,238,248,232,251]
- ▸Apixaban has been systematically compared with enoxaparin for postoperative VTE prevention after gynecologic cancer surgery, but prophylaxis remains individualized.[246]
- ▸In APS, severe thrombocytopenia is defined as a platelet nadir <50 G/L; the cited study does not establish a universal anticoagulation threshold.[129]
- ▸Geriatric RCC patients with venous tumor thrombus had greater comorbidity and ASA burden, supporting multidisciplinary individualized surgical selection.[234]
Children and adolescents
Children with extremity or nonextremity venous thromboembolism (VTE) require follow-up after acute treatment to identify postthrombotic sequelae; however, the international ASTRO-Kids survey found that monitoring, diagnostic assessment, and treatment practices were not standardized across pediatric thrombosis centers, with practice patterns differing between neonatal, nonneonatal, extremity, and nonextremity thrombosis.[245] Follow-up should therefore be individualized to the thrombus location, age, symptoms, functional impact, and local pediatric thrombosis expertise rather than assumed to follow a uniform schedule.[245]
Pregnancy and trauma
Pregnancy-associated trauma represents a high-risk setting in which physiologic changes of pregnancy may alter trauma response and complication risk, while evidence guiding risk stratification and time-sensitive interventions remains limited.[252] In a national trauma-database cohort of pregnant patients aged 18–45 years with moderate-to-severe polytrauma, maternal mortality, early blood transfusion, and timing of emergency caesarean delivery were specifically evaluated; these findings are relevant when balancing urgent obstetric, hemorrhagic, and thrombotic risks, although the available abstract does not provide DVT-specific treatment estimates.[252]
Cancer-associated thrombosis
Cancer substantially broadens the differential diagnosis and management context for DVT. In adults with active cancer and isolated distal lower-extremity DVT and/or subsegmental pulmonary embolism, a retrospective cohort study evaluated anticoagulation strategies, recurrent VTE at 6 months, and major bleeding during 12 months of follow-up; the study highlights that management of these “small” VTE presentations remains uncertain and requires assessment of recurrence, bleeding, cancer status, and competing mortality risk.[22]
For isolated, bland cancer-associated splanchnic vein thrombosis (CA-SpVT), evidence is also limited. A dual-center cohort of 437 adults excluded tumor thrombus and examined anticoagulation in relation to major bleeding, usual-site VTE recurrence, and splanchnic-vein progression or recanalization, using weighted analyses adjusted for cancer type, stage, thrombosis location, and symptoms.[253] Bland thrombus should be distinguished from portal or venous tumor thrombus, because the latter reflects intravascular tumor extension and is evaluated primarily through oncologic and surgical strategies rather than management algorithms for ordinary DVT.[183]D[238][248]C[232][234][251]C
Gynecologic oncology and uterine cancer surgery
After gynecologic cancer surgery, a systematic review and meta-analysis compared oral apixaban with enoxaparin for postoperative VTE prevention; the review included randomized trials and cohort studies identified through August 2025 and was conducted according to PRISMA 2020 methods.[246] These data address efficacy, safety, and potential adherence advantages of oral prophylaxis, but treatment selection remains dependent on bleeding risk, renal function, drug interactions, oral intake, and the specific operation.[246]
For minimally invasive hysterectomy, a 2000–2024 cohort of 53,744 women compared laparoscopic and robotic procedures and assessed 90-day DVT or pulmonary embolism, including patients who did not receive low-molecular-weight heparin.[254] The study was designed to evaluate whether pharmacologic prophylaxis is necessary in this setting, but its observational design means that procedure-specific VTE risk and prophylaxis decisions should not be generalized to open surgery, cancer-associated high-risk patients, or patients with additional thrombosis risk factors.[254] In uterine-cancer minimally invasive surgery, a National Surgical Quality Improvement Program study examined BMI, length of stay, and postoperative complications among 2013–2022 cases; BMI was therefore a relevant perioperative risk-stratification variable, although the abstract does not provide a DVT-specific effect estimate.[114]D
Prophylactic lymphovenous bypass performed during axillary lymph-node dissection was evaluated in 61,819 cases from the 2013–2022 NSQIP database, including 572 cases with concurrent bypass.[250] The analysis tracked 30-day complications, including DVT, and provides safety-context data for breast-cancer patients undergoing lymphatic reconstruction, but it does not establish prophylactic anticoagulation recommendations.[250]
Hematologic malignancy and targeted therapy
In multiple myeloma treated with proteasome inhibitors and/or immunomodulatory drugs, a retrospective study of 357 newly diagnosed patients found a median age of 71 years and a 1-year cumulative VTE incidence of 4.9%; it specifically evaluated the geriatric nutritional risk index (GNRI), using 92 as the prespecified cutoff, as a marker associated with VTE risk.[249] Nutritional status may therefore complement, but not replace, clinical thrombosis and bleeding assessment in older adults with myeloma.[249]
In hormone-receptor-positive, HER2-negative, nonmetastatic breast cancer, a systematic review and meta-analysis of seven studies evaluated VTE risk associated with cyclin-dependent kinase 4/6 inhibitors combined with endocrine therapy.[197] The evidence supports recognizing CDK4/6 inhibitor exposure as a potential contributor to VTE risk, while individual prophylaxis decisions require integration of cancer treatment, prior VTE, comorbidity, and bleeding risk.[197]
Neurologic and ophthalmic populations
Adult-type diffuse gliomas carry clinically relevant VTE risk. A retrospective neuro-oncology-center study of 147 patients and a systematic review incorporating eight observational cohorts with 7,779 patients examined VTE frequency and determinants, including glioblastoma, astrocytoma, and oligodendroglioma populations.[247] Intracranial disease creates a particularly important balance between thrombosis prevention or treatment and intracranial bleeding risk; the cited observational evidence does not define a universal anticoagulant regimen.[247]
Systemic tyrosine kinase inhibitor therapy has also been investigated in relation to retinal vascular occlusion. A US multi-institutional electronic-health-record cohort evaluated retinal artery and retinal vein occlusions in adults with cancer who had no prior retinal vascular occlusion or maculopathy, including exposure to TKIs with and without anti-VEGF activity.[255]C New visual symptoms during TKI therapy warrant prompt ophthalmic evaluation because retinal vascular events may mimic or accompany other treatment-related ocular complications.[255]C
Antiphospholipid syndrome and thrombocytopenia
Among 432 patients with antiphospholipid syndrome, 142 (32.9%) developed thrombocytopenia during follow-up; severe thrombocytopenia was defined as a platelet nadir <50 G/L, moderate thrombocytopenia as 50–130 G/L, and no thrombocytopenia as ≥130 G/L.[129] APS patients with thrombocytopenia require simultaneous assessment of thrombotic risk, bleeding risk, platelet trajectory, autoimmune disease activity, and the indication for anticoagulation; the retrospective study describes management and outcomes but does not provide a universal platelet-based anticoagulation threshold.[129]
Older adults and venous tumor thrombus
For geriatric patients with renal-cell carcinoma and venous tumor thrombus, a propensity-matched retrospective study compared 88 patients aged ≥70 years with younger patients among 542 surgical cases.[234] Geriatric patients had more comorbidities (82.95% versus 64.54%) and a higher proportion with ASA class ≥3 (26.14% versus 14.10%), emphasizing the need for individualized perioperative selection rather than age alone.[234]
Studies of metastatic renal-cell carcinoma with venous tumor thrombus evaluated cytoreductive nephrectomy plus thrombectomy using inverse-probability weighting, while other cohorts examined preoperative targeted therapy for inferior vena-cava tumor-thrombus downgrading.[232][251]C These interventions address tumor thrombus, not routine bland DVT, and should be considered within multidisciplinary oncologic, surgical, and perioperative assessment.[232][251]C
Hepatocellular carcinoma with portal-vein tumor thrombus
Portal-vein tumor thrombus (PVTT) is an oncologic manifestation of HCC with poor prognosis and should not be conflated with bland portal-vein thrombosis.[183]D[238][248]C[41]D Retrospective studies evaluated liver resection versus transarterial chemoembolization combined with PD-1 inhibition and lenvatinib, conversion therapy using predominantly systemic therapy plus TACE, HAIC with TKIs with or without PD-1 inhibition, and HAIC combined with apatinib plus camrelizumab for type Vp4 disease.[183]D[238][248]C[41]D These studies suggest active multimodality treatment and potential surgical conversion are being investigated, but their retrospective designs do not establish a standard DVT anticoagulation strategy for PVTT.[183]D[238][248]C[41]D
| Population | Evidence focus | Practical implication |
|---|---|---|
| Children with VTE | Follow-up for postthrombotic sequelae; practice variation across centers.[245] | Individualize surveillance by age, location, symptoms, and expertise.[245] |
| Active cancer with distal DVT/SSPE | Anticoagulation, recurrence, and major bleeding outcomes were studied retrospectively.[22] | Weigh recurrence, bleeding, cancer status, and competing mortality.[22] |
| Cancer-associated splanchnic thrombosis | Cohort of 437 patients with isolated bland CA-SpVT; tumor thrombus excluded.[253] | Confirm whether thrombus is bland or tumor-related before applying a DVT framework.[253] |
| APS with thrombocytopenia | Severe <50 G/L; moderate 50–130 G/L; no thrombocytopenia ≥130 G/L.[129] | Reassess platelet trend, bleeding, thrombosis, and anticoagulation indication.[129] |
| Geriatric RCC with VTT | Patients ≥70 years had more comorbidity and ASA ≥3 burden.[234] | Use multidisciplinary perioperative risk assessment.[234] |
References
- [1]
Eklof B, Perrin M, Delis KT et al.. “Updated terminology of chronic venous disorders: the VEIN-TERM transatlantic interdisciplinary consensus document.” Journal of vascular surgery (2009). PMID: 19216970 ↗
L1cGUIDELINECited in: Definition, Synonyms, and Classification - [2]
Sun CR, Liu MY, Ni QH et al.. “Clinical Guidelines on Compression Therapy in Venous Diseases.” Annals of vascular surgery (2025). PMID: 39032593 ↗
L1cGUIDELINECited in: Definition, Synonyms, and Classification - [3]
Stevens SM, Woller SC, Baumann Kreuziger L et al.. “Antithrombotic Therapy for VTE Disease: Compendium and Review of CHEST Guidelines 2012-2021.” Chest (2024). PMID: 38458430 ↗
L5REVIEW_NARRATIVECited in: Definition, Synonyms, and Classification - [4]
Bayraktar Y. “Portal ductopathy: clinical importance and nomenclature.” World journal of gastroenterology (2011). PMID: 21472098 ↗
L5REVIEW_NARRATIVECited in: Definition, Synonyms, and Classification - [5]
Kumar A, Sharma P, Arora A. “Review article: portal vein obstruction--epidemiology, pathogenesis, natural history, prognosis and treatment.” Alimentary pharmacology & therapeutics (2015). PMID: 25475582 ↗
L5REVIEW_NARRATIVECited in: Definition, Synonyms, and Classification - [6]
Shenoy A, Davis JPE. “Contemporary management of portal vein thromboses in patients with and without cirrhosis.” Current opinion in gastroenterology (2025). PMID: 39998941 ↗
L5REVIEW_NARRATIVECited in: Definition, Synonyms, and Classification - [7]
Bayraktar Y, Harmanci O. “Etiology and consequences of thrombosis in abdominal vessels.” World journal of gastroenterology (2006). PMID: 16534866 ↗
L5REVIEW_NARRATIVECited in: Definition, Synonyms, and Classification - [8]
Harmanci O, Bayraktar Y. “Portal hypertension due to portal venous thrombosis: etiology, clinical outcomes.” World journal of gastroenterology (2007). PMID: 17552000 ↗
L5REVIEW_NARRATIVECited in: Definition, Synonyms, and Classification - [9]
Yamagishi T, Hikone M, Sugiyama K et al.. “Purpura fulminans with Lemierre's syndrome caused by Gemella bergeri and Eikenella corrodens: a case report.” BMC infectious diseases (2018). PMID: 30340466 ↗
L4CASE_REPORTCited in: Definition, Synonyms, and Classification - [10]
Kahn F, Linder A, Petersson AC et al.. “Axillary abscess complicated by venous thrombosis: identification of Streptococcus pyogenes by 16S PCR.” Journal of clinical microbiology (2010). PMID: 20592151 ↗
L4CASE_REPORTCited in: Definition, Synonyms, and Classification - [11]
Kupfer M, Kucer BT, Kupfer H et al.. “Persons With Chronic Spinal Cord Injuries in the Emergency Department: a Review of a Unique Population.” The Journal of emergency medicine (2018). PMID: 29807681 ↗
L5REVIEW_NARRATIVECited in: Definition, Synonyms, and Classification - [12]
Comarmond C, Mirault T, Biard L et al.. “Takayasu Arteritis and Pregnancy.” Arthritis & rheumatology (Hoboken, N.J.) (2015). PMID: 26315109 ↗
L5OTHERCited in: Definition, Synonyms, and Classification - [13]
de Haan HG, van Hylckama Vlieg A, van der Gaag KJ et al.. “Male-specific risk of first and recurrent venous thrombosis: a phylogenetic analysis of the Y chromosome.” Journal of thrombosis and haemostasis : JTH (2016). PMID: 27495181 ↗
L5OTHERCited in: Definition, Synonyms, and Classification - [14]
Zhang X, Durham KM, Garza AA et al.. “Portal vein thrombosis, hepatic decompensation, and survival in patients with porto-sinusoidal vascular disease and portal hypertension.” Journal of gastroenterology (2023). PMID: 36692825 ↗
L5OTHERCited in: Definition, Synonyms, and Classification - [15]
Munk MR, Kashani AH, Tadayoni R et al.. “Recommendations for OCT Angiography Reporting in Retinal Vascular Disease: A Delphi Approach by International Experts.” Ophthalmology. Retina (2022). PMID: 35202889 ↗
L5OTHERCited in: Definition, Synonyms, and Classification - [16]
Bayona Molano MDP, Brackett W, Mena P et al.. “Complex filter removal using forceps from combined transfemoral and transjugular approach unhooking the filter apex using forceps and dual access: Two case reports.” Journal of cardiac surgery (2022). PMID: 35819367 ↗
L4CASE_REPORTCited in: Definition, Synonyms, and Classification - [17]
Shen Y, Jiang Y, Wang Y et al.. “Increased risk of venous thromboembolism in children and teenagers with inflammatory bowel disease: a systematic review and meta-analysis.” PeerJ (2026). PMID: 41940394 ↗
L2aSR_OBSCited in: Epidemiology and Risk Factors - [18]
Wen X, Wu H, He Y et al.. “Efficacy and safety of cyanoacrylate ablation vs endovenous radiofrequency ablation for varicose veins in chronic great saphenous vein insufficiency: A systematic review and meta-analysis.” Journal of vascular surgery. Venous and lymphatic disorders (2026). PMID: 41866115 ↗
L2aSR_OBSCited in: Epidemiology and Risk Factors - [19]
Das S, Simunovic N, Di Maria F et al.. “Prophylaxis does not prevent symptomatic venous thromboembolism following anterior cruciate ligament surgery: a systematic review and meta-analysis.” Journal of ISAKOS : joint disorders & orthopaedic sports medicine (2026). PMID: 41850529 ↗
L2aSR_OBSCited in: Epidemiology and Risk Factors - [20]
Gong M, Kong J, Gu J et al.. “Who benefits from a filter? Developing clinical prediction models for thrombus dislodgement in hospitalized patients with deep vein thrombosis: A multicenter retrospective study.” European journal of radiology (2026). PMID: 41946015 ↗
L2bCOHORTCited in: Epidemiology and Risk Factors, Diagnosis and Workup - [21]
Chen H, Chen K, Xie X et al.. “Association between triglyceride glucose- systemic immune inflammation index and deep venous thrombosis in fresh fracture patient: a real-world retrospective study.” Frontiers in endocrinology (2026). PMID: 41907552 ↗
L2bCOHORTCited in: Epidemiology and Risk Factors - [22]
Kou R, Mallick R, Brown C et al.. “Anticoagulation management and outcomes in patients with cancer-associated small venous thromboembolism: a retrospective cohort study.” Journal of thrombosis and haemostasis : JTH (2026). PMID: 41791657 ↗
L2bCOHORTCited in: Epidemiology and Risk Factors - [23]
Wardak YH, Chung YE, Maingard J et al.. “Quality of life following endovascular treatment of proximal lower limb DVT: A systematic review and meta-analysis.” Journal of vascular and interventional radiology : JVIR (2026). PMID: 41905683 ↗
L2aSR_OBSCited in: Epidemiology and Risk Factors - [24]
Botolin P, Robles R, Keshishian C et al.. “Impact of Stroke History and Interval on Outcomes of Total Hip Arthroplasty: A Retrospective Cohort Study.” Orthopedics (2026). PMID: 41885516 ↗
L2bCOHORTCited in: Epidemiology and Risk Factors, Diagnosis and Workup - [25]
Zhai Y, Cao X, Zheng S et al.. “[Comparative observation of analgesic efficacy between liposomal bupivacaine and "cocktail" therapy following artificial intelligence-assisted direct anterior approach total hip arthroplasty: A prospective randomized controlled study].” Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery (2026). PMID: 41981425 ↗
L1bRCTCited in: Epidemiology and Risk Factors, History and Physical Examination, Diagnosis and Workup - [26]
Li Y, Wang S, Zhao X. “Risk factors for TIVAD-related venous thrombosis in Chinese breast cancer patients undergoing chemotherapy: A single-center retrospective study.” Medicine (2026). PMID: 41861226 ↗
L2bCOHORTCited in: Epidemiology and Risk Factors, Diagnosis and Workup, Special Populations - [27]
Skeith L, Bates SM. “Sex Hormone Influences on Venous Thrombotic and Cardiovascular Risk.” The New England journal of medicine (2026). PMID: 41985134 ↗
L5REVIEW_NARRATIVECited in: Epidemiology and Risk Factors - [28]
Hou J, Mu G, Zhang Z et al.. “Hematological toxicities and thrombosis risk associated with immune checkpoint inhibitors: a pharmacovigilance study from 2014 to 2024.” Cancer immunology, immunotherapy : CII (2026). PMID: 41984243 ↗
L5OTHERCited in: Epidemiology and Risk Factors, Special Populations - [29]
Mansour M, Asi AR, Massalha E et al.. “Residual Perfusion Defects after Acute Pulmonary Embolism: Prevalence, Determinants, and Clinical Impact.” The American journal of medicine (2026). PMID: 41941949 ↗
L5OTHERCited in: Epidemiology and Risk Factors - [30]
Gonzalez HC, Gordon SC, Trudeau S et al.. “Impact of Disease-Specific Treatment and Non-Selective Beta Blockers on Risk of PVT in Cirrhotic Patients With HCV or PBC.” Liver international : official journal of the International Association for the Study of the Liver (2026). PMID: 41933920 ↗
L5OTHERCited in: Epidemiology and Risk Factors - [31]
Jones GD, Raja S, Ahmad U et al.. “Prospectively Screening for Venous Thromboembolism in Patients with Esophagectomy for Cancer Improves Survival: The Complexity of Simplicity.” The Journal of thoracic and cardiovascular surgery (2026). PMID: 41932434 ↗
L5OTHERCited in: Epidemiology and Risk Factors - [32]
Sohail A, Powers MT, Suarez T et al.. “Direct Oral Anticoagulants Are Associated With Less Bleeding Risk Than Warfarin in Patients Undergoing Liver Resections.” The Journal of surgical research (2026). PMID: 41921475 ↗
L5OTHERCited in: Epidemiology and Risk Factors - [33]
Yang L, Zhang Z, Li C et al.. “Effect of different durations of compression therapy on quality of life and recurrence after thermal ablation for varicose veins: a protocol for a prospective, multicenter, randomized controlled trial.” Frontiers in medicine (2026). PMID: 41907264 ↗
L5OTHERCited in: Epidemiology and Risk Factors - [34]
Yang S, Li G, Li Y et al.. “In-hospital deep vein thrombosis after tibial plateau fractures: incidence, laterality/anatomy, and risk factors in a multicenter retrospective cohort of 3366 patients.” Journal of orthopaedics and traumatology : official journal of the Italian Society of Orthopaedics and Traumatology (2026). PMID: 41886203 ↗
L5OTHERCited in: Epidemiology and Risk Factors - [35]
Horton CE, Wi MS, Sayegh M et al.. “Short-term outcomes of ultrasound-assisted catheter-directed thrombolysis and mechanical thrombectomy in management of intermediate-risk pulmonary embolism.” Journal of vascular surgery. Venous and lymphatic disorders (2026). PMID: 41866114 ↗
L5OTHERCited in: Epidemiology and Risk Factors - [36]
Mao J, Qin L, Gao M et al.. “Perioperative management of colorectal surgical patients receiving a direct oral anticoagulant: a scoping review, particular emphasis on procedure-specific risks, and pharmacogenomics.” Frontiers in cardiovascular medicine (2026). PMID: 41835471 ↗
L5REVIEW_NARRATIVECited in: Epidemiology and Risk Factors - [37]
Doukhi D, Aghetti A, Siguret V et al.. “Specific Features of Cerebral Venous Thrombosis Associated With Iron Deficiency Anemia.” Journal of the American Heart Association (2026). PMID: 41804921 ↗
L5OTHERCited in: Epidemiology and Risk Factors - [38]
Doiron JE, Corpodean F, Kachmar M et al.. “Prevalence of early marginal ulcer in sleeve to bypass conversions: an analysis of the 2020-2022 MBSAQIP.” Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery (2026). PMID: 41791958 ↗
L5OTHERCited in: Epidemiology and Risk Factors - [39]
Fu P, Li Y, Wang C et al.. “Deletion of platelet STK10 impairs deep vein thrombus formation.” Journal of thrombosis and haemostasis : JTH (2026). PMID: 41791658 ↗
L5OTHERCited in: Epidemiology and Risk Factors - [40]
Daghlas I, Perez-Alcantara M, Gill D. “Direct Oral Anticoagulant Protein Targets and Risk of Cerebral Venous Thrombosis: A Mendelian Randomization Study.” Neurology (2026). PMID: 41785432 ↗
L5OTHERCited in: Epidemiology and Risk Factors - [41]
Wu S, Qiu F, Zhang F et al.. “Hepatic arterial infusion chemotherapy combined with apatinib plus camrelizumab for advanced hepatocellular carcinoma with type Vp4 portal vein tumor thrombosis: a multicenter propensity score-matching analysis.” Frontiers in immunology (2026). PMID: 41782861 ↗
L5OTHERCited in: Epidemiology and Risk Factors, Diagnosis and Workup, Special Populations - [42]
Ye H, Li J, Du L et al.. “Development and validation of a deep vein thrombosis risk assessment tool for surgical patients aged 75 years and older.” BMC geriatrics (2026). PMID: 41782093 ↗
L5OTHERCited in: Epidemiology and Risk Factors, Diagnosis and Workup - [43]
Sobih NM, Vellema J, van de Munckhof A et al.. “Impact of anaemia severity on functional outcome in patients with cerebral venous thrombosis: a DOAC-CVT substudy.” European stroke journal (2026). PMID: 41758562 ↗
L5OTHERCited in: Epidemiology and Risk Factors - [44]
Ke X, Liu Y, Chen X et al.. “Association between preoperative anemia and postoperative delirium in elderly patients undergoing total hip arthroplasty with combined spinal-epidural anesthesia: A retrospective cohort study.” Journal of anesthesia and translational medicine (2025). PMID: 41929925 ↗
L2bCOHORTCited in: Epidemiology and Risk Factors - [45]
Kamada K, Fukaya E, Iwata E et al.. “Disaster-associated venous thromboembolism countermeasures in Japan: Insights from past major earthquakes.” Journal of vascular surgery. Venous and lymphatic disorders (2026). PMID: 40935330 ↗
L5REVIEW_NARRATIVECited in: Etiology and Triggering Factors, Pathophysiology - [46]
Liu S, Shen Y, Chen J et al.. “The critical role of platelets in venous thromboembolism: Pathogenesis, clinical status, and emerging therapeutic strategies.” Blood reviews (2025). PMID: 40382294 ↗
L5REVIEW_NARRATIVECited in: Etiology and Triggering Factors, Pathophysiology - [47]
Muscat-Baron L, Borg AL, Attard LM et al.. “Cancer-Associated Abdominal Vein Thrombosis.” Cancers (2023). PMID: 37958466 ↗
L5REVIEW_NARRATIVECited in: Etiology and Triggering Factors - [48]
Johnson RR, Faustino EVS. “Central venous catheter-associated deep vein thrombosis in critically ill pediatric patients: risk factors, prevention, and treatment.” Current opinion in pediatrics (2022). PMID: 35634701 ↗
L5REVIEW_NARRATIVECited in: Etiology and Triggering Factors - [49]
Hembrom AA, Srivastava S, Garg I et al.. “MicroRNAs in venous thrombo-embolism.” Clinica chimica acta; international journal of clinical chemistry (2020). PMID: 32017924 ↗
L5REVIEW_NARRATIVECited in: Etiology and Triggering Factors - [50]
Caprini JA. “Risk assessment as a guide for the prevention of the many faces of venous thromboembolism.” American journal of surgery (2010). PMID: 20103082 ↗
L5REVIEW_NARRATIVECited in: Etiology and Triggering Factors - [51]
Levine MN. “Adjuvant therapy and thrombosis: how to avoid the problem?” Breast (Edinburgh, Scotland) (2007). PMID: 17720502 ↗
L5REVIEW_NARRATIVECited in: Etiology and Triggering Factors - [52]
Didembourg M, Morimont L, De Gottal E et al.. “The maternal hemostatic shift: Understanding VTE risk in pregnancy and postpartum.” Thrombosis research (2026). PMID: 41352199 ↗
L5REVIEW_NARRATIVECited in: Etiology and Triggering Factors, Pathophysiology, Special Populations - [53]
Mehta JL, Calcaterra G, Bassareo PP. “COVID-19, thromboembolic risk, and Virchow's triad: Lesson from the past.” Clinical cardiology (2020). PMID: 33176009 ↗
L5REVIEW_NARRATIVECited in: Etiology and Triggering Factors - [54]
Liu A, Minasian RA, Maniago E et al.. “Venous Thromboembolism Chemoprophylaxis in Burn Patients: A Literature Review and Single-Institution Experience.” Journal of burn care & research : official publication of the American Burn Association (2021). PMID: 32842151 ↗
L5REVIEW_NARRATIVECited in: Etiology and Triggering Factors - [55]
Stone J, Hangge P, Albadawi H et al.. “Deep vein thrombosis: pathogenesis, diagnosis, and medical management.” Cardiovascular diagnosis and therapy (2017). PMID: 29399531 ↗
L5REVIEW_NARRATIVECited in: Etiology and Triggering Factors - [56]
Byrnes JR, Wolberg AS. “New findings on venous thrombogenesis.” Hamostaseologie (2017). PMID: 27878206 ↗
L5REVIEW_NARRATIVECited in: Etiology and Triggering Factors - [57]
Congly SE, Lee SS. “Portal vein thrombosis: should anticoagulation be used?” Current gastroenterology reports (2013). PMID: 23314804 ↗
L5REVIEW_NARRATIVECited in: Etiology and Triggering Factors - [58]
López JA, Chen J. “Pathophysiology of venous thrombosis.” Thrombosis research (2009). PMID: 19303501 ↗
L5REVIEW_NARRATIVECited in: Etiology and Triggering Factors - [59]
Haas P, Landgraf H. “Studies on travel-related thrombosis.” VASA. Zeitschrift fur Gefasskrankheiten (2008). PMID: 19003739 ↗
L5REVIEW_NARRATIVECited in: Etiology and Triggering Factors - [60]
Merli GJ. “Pathophysiology of venous thrombosis, thrombophilia, and the diagnosis of deep vein thrombosis-pulmonary embolism in the elderly.” Clinics in geriatric medicine (2006). PMID: 16377468 ↗
L5REVIEW_NARRATIVECited in: Etiology and Triggering Factors - [61]
Savulescu-Fiedler I, Siliste RN, Homentcovschi C et al.. “The role of endothelial cell protein C receptor gene polymorphism in venous thromboembolic disease: a case report and literature review.” Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis (2025). PMID: 40643034 ↗
L4CASE_REPORTCited in: Etiology and Triggering Factors, Pathophysiology - [62]
Sasson I, Sorin V, Ziv-Baran T et al.. “Unexpected early pulmonary thrombi in war injured patients.” European radiology (2026). PMID: 40833493 ↗
L5OTHERCited in: Etiology and Triggering Factors - [63]
Gebhard CE, Zellweger N, Gebhard C et al.. “Prone Positioning as a Potential Risk Factor for Deep Vein Thrombosis in COVID-19 Patients: A Hypothesis Generating Observation.” Journal of clinical medicine (2021). PMID: 35011843 ↗
L5OTHERCited in: Etiology and Triggering Factors - [64]
Rajeeva Pandian NK, Walther BK, Suresh R et al.. “Microengineered Human Vein-Chip Recreates Venous Valve Architecture and Its Contribution to Thrombosis.” Small (Weinheim an der Bergstrasse, Germany) (2020). PMID: 33205630 ↗
L5OTHERCited in: Etiology and Triggering Factors - [65]
Lurie JM, Png CYM, Subramaniam S et al.. “Virchow's triad in "silent" deep vein thrombosis.” Journal of vascular surgery. Venous and lymphatic disorders (2019). PMID: 31078515 ↗
L5OTHERCited in: Etiology and Triggering Factors - [66]
Alturki N, Alkahtani M, Daghistani M et al.. “Incidence and risk factors for deep vein thrombosis among pediatric burn patients.” Burns : journal of the International Society for Burn Injuries (2019). PMID: 31018912 ↗
L5OTHERCited in: Etiology and Triggering Factors - [67]
Avila ML, Duan L, Cipolla A et al.. “Postthrombotic syndrome following upper extremity deep vein thrombosis in children.” Blood (2014). PMID: 24957144 ↗
L5OTHERCited in: Etiology and Triggering Factors - [68]
Wilson TJ, Brown DL, Meurer WJ et al.. “Risk factors associated with peripherally inserted central venous catheter-related large vein thrombosis in neurological intensive care patients.” Intensive care medicine (2012). PMID: 22113818 ↗
L5OTHERCited in: Etiology and Triggering Factors - [69]
Bittencourt PL, Couto CA, Ribeiro DD. “Portal vein thrombosis and budd-Chiari syndrome.” Clinics in liver disease (2009). PMID: 19150317 ↗
L5OTHERCited in: Etiology and Triggering Factors - [70]
Bagot CN, Arya R. “Virchow and his triad: a question of attribution.” British journal of haematology (2008). PMID: 18783400 ↗
L5OTHERCited in: Etiology and Triggering Factors - [71]
Shaydakov ME, Diaz JA, Eklöf B et al.. “Venous valve hypoxia as a possible mechanism of deep vein thrombosis: a scoping review.” International angiology : a journal of the International Union of Angiology (2024). PMID: 38864688 ↗
L5REVIEW_NARRATIVECited in: Etiology and Triggering Factors - [72]
Sapota-Zaręba K, Nasierowski T. “The risk of pulmonary embolism in the context of various clinical situations and management in psychiatric patients.” Psychiatria polska (2023). PMID: 38345121 ↗
L5REVIEW_NARRATIVECited in: Etiology and Triggering Factors - [73]
Malone PC, Agutter PS. “The aetiology of deep venous thrombosis.” QJM : monthly journal of the Association of Physicians (2006). PMID: 16905749 ↗
L5REVIEW_NARRATIVECited in: Etiology and Triggering Factors - [74]
Stojanovic M, Djuric M, Nenadic I et al.. “Vascular Complications of Long COVID-From Endothelial Dysfunction to Systemic Thrombosis: A Systematic Review.” International journal of molecular sciences (2025). PMID: 41516301 ↗
L2aSR_OBSCited in: Pathophysiology - [75]
Gandhi SD, Mohanty S, von Riegen H et al.. “Efficacy and Safety of Chemical Venous Thromboembolism Prophylaxis in Spine Trauma Patients: A Systematic Review and Meta-analysis Comparing Anticoagulant Types.” Clinical spine surgery (2026). PMID: 40071770 ↗
L2aSR_OBSCited in: Pathophysiology - [76]
Shi H, Zhao Y, Shi X et al.. “Effects of traditional Chinese medicine decoctions on coagulation and deep vein thrombosis after total hip arthroplasty: Network meta-analysis.” Explore (New York, N.Y.) (2026). PMID: 41232428 ↗
L2aSR_OBSCited in: Pathophysiology - [77]
Krupa-Zabiegała J, Michel PS, Stępień K et al.. “Higher citrullinated histone H3 is associated with postthrombotic syndrome: a cohort study.” Journal of thrombosis and haemostasis : JTH (2026). PMID: 41192568 ↗
L2bCOHORTCited in: Pathophysiology - [78]
Peng J, Long S, Feng L. “Deep Vein Thrombosis Prevention in Acute Ischemic Stroke Patients with Lower Limb Paralysis: A Narrative Review.” Journal of clinical medicine (2026). PMID: 41899016 ↗
L5REVIEW_NARRATIVECited in: Pathophysiology - [79]
Sparić R, Stojković M, Šarac M et al.. “Venous Thromboembolism Associated with Uterine Fibroids: A Review of Reported Cases.” Journal of clinical medicine (2026). PMID: 41598382 ↗
L5REVIEW_NARRATIVECited in: Pathophysiology, History and Physical Examination - [80]
Albasanz-García P, Ward MP, Norris LA. “Mechanisms of anticancer treatment-induced arterial and venous thrombosis.” Journal of thrombosis and haemostasis : JTH (2026). PMID: 41203043 ↗
L5REVIEW_NARRATIVECited in: Pathophysiology - [81]
Limper U, Jordan J. “Neck-vein thrombosis during spaceflight.” British journal of clinical pharmacology (2026). PMID: 41035389 ↗
L5REVIEW_NARRATIVECited in: Pathophysiology - [82]
Piazza G, Krishnathasan D, Hamade N et al.. “Superficial Vein Thrombosis: A Review.” JAMA (2025). PMID: 40952730 ↗
L5REVIEW_NARRATIVECited in: Pathophysiology - [83]
Dhar R, Dos Passos RR, Gower RM et al.. “Toward targeting of inflammasome signaling in venous thrombosis.” Journal of thrombosis and haemostasis : JTH (2025). PMID: 40946806 ↗
L5REVIEW_NARRATIVECited in: Pathophysiology - [84]
Galanaud JP, Laroche JP, Righini M. “The history and historical treatments of deep vein thrombosis: toward the era of new anticoagulants.” Journal of thrombosis and haemostasis : JTH (2025). PMID: 40714194 ↗
L5REVIEW_NARRATIVECited in: Pathophysiology - [85]
Shao W, Wang Z, Wu J et al.. “Targeting toll-like receptors: unveiling potential therapeutic strategies for deep vein thrombosis.” Frontiers in immunology (2025). PMID: 40510367 ↗
L5REVIEW_NARRATIVECited in: Pathophysiology - [86]
Byun JH, Jung J, Woo J. “Clonal hematopoiesis and thromboembolic diseases: a review.” Journal of thrombosis and haemostasis : JTH (2025). PMID: 40499722 ↗
L5REVIEW_NARRATIVECited in: Pathophysiology - [87]
Badulescu OV, Ciocoiu M, Vladeanu MC et al.. “The Role of Platelet Dysfunctions in the Pathogenesis of the Hemostatic-Coagulant System Imbalances.” International journal of molecular sciences (2025). PMID: 40141398 ↗
L5REVIEW_NARRATIVECited in: Pathophysiology - [88]
Budnik I, Kumskova M, Chauhan AK. “Metabolic pathways in deep vein thrombosis: a new frontier for therapeutic intervention.” Blood (2025). PMID: 40132161 ↗
L5REVIEW_NARRATIVECited in: Pathophysiology - [89]
Davis J, Maranto M, Kennedy J et al.. “Transforming Growth Factors in Venous Thrombus Formation and Resolution.” Arteriosclerosis, thrombosis, and vascular biology (2025). PMID: 40109257 ↗
L5REVIEW_NARRATIVECited in: Pathophysiology - [90]
Cox C, Roberts LN. “Basics of diagnosis and treatment of venous thromboembolism.” Journal of thrombosis and haemostasis : JTH (2025). PMID: 39938684 ↗
L5REVIEW_NARRATIVECited in: Pathophysiology - [91]
Secades D, Dufner Krieger S, Hidalgo Ramos RA et al.. “Incidence of Deep Vein Thrombosis in Patients With COVID-19: A Systematic Review.” Cureus (2025). PMID: 40861621 ↗
L2aSR_OBSCited in: Pathophysiology - [92]
Papadakis E, Gavriilaki E, Kotsiou N et al.. “Fright of Long-Haul Flights: Focus on Travel-Associated Thrombosis.” Seminars in thrombosis and hemostasis (2025). PMID: 40015328 ↗
L5REVIEW_NARRATIVECited in: Pathophysiology - [93]
Kell DB, Pretorius E. “The Proteome Content of Blood Clots Observed Under Different Conditions: Successful Role in Predicting Clot Amyloid(ogenicity).” Molecules (Basel, Switzerland) (2025). PMID: 39942772 ↗
L5REVIEW_NARRATIVECited in: Pathophysiology - [94]
Denorme F, Portier I, Castro H et al.. “Platelet mTOR Is a Regulator of Sterile Immunothrombosis.” Arteriosclerosis, thrombosis, and vascular biology (2026). PMID: 41783929 ↗
L5OTHERCited in: Pathophysiology - [95]
Shen YJ, Nie ZY, Zhang JQ et al.. “Cyanidin-3-O-glucoside promotes late-stage venous thrombus resolution in mice, accompanied by reduced macrophage M1-associated inflammation and attenuated HIF-1α-linked signaling.” Food & function (2026). PMID: 41734240 ↗
L5OTHERCited in: Pathophysiology - [96]
Chen C, Ge X, Fu D et al.. “Endothelial Cell-Specific Molecule-1 (ESM1): An Endogenous Anticoagulant and Protective Factor in Venous Thrombosis.” Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2026). PMID: 41517829 ↗
L5OTHERCited in: Pathophysiology - [97]
Suzuki N, Suzuki A, Tamura S et al.. “Antithrombotic Therapy on Antithrombin Resistance in a Mouse Model.” Arteriosclerosis, thrombosis, and vascular biology (2026). PMID: 41503699 ↗
L5OTHERCited in: Pathophysiology - [98]
Wongweerakit O, Sangthong B, Akaraborworn O et al.. “De novo pulmonary embolism following chest trauma: fact or fiction?” European journal of trauma and emergency surgery : official publication of the European Trauma Society (2025). PMID: 41410754 ↗
L5OTHERCited in: Pathophysiology - [99]
Noda H, Yutani C, Takahashi S et al.. “Morphological Visualization of Thrombi During Catheter-Directed Fibrinolytic Therapy for Pulmonary Thromboembolism.” The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society (2026). PMID: 41292114 ↗
L5OTHERCited in: Pathophysiology - [100]
Shi TL, Yang ZB, Zhang YQ et al.. “Vibration-stimulation device-assisted enhanced recovery after lower limb fracture surgery: A randomized controlled trial.” International orthopaedics (2026). PMID: 41413326 ↗
L1bRCTCited in: History and Physical Examination - [101]
Betensky M, Mosha M, Ashour D et al.. “Postthrombotic syndrome-related chronic limb pain in children: findings from the Multicenter Evaluation of the Duration of Therapy for Thrombosis in Children (Kids-DOTT) trial.” Journal of thrombosis and haemostasis : JTH (2026). PMID: 41407160 ↗
L1bRCTCited in: History and Physical Examination - [102]
Le Gal G, Robert-Ebadi H, Thiruganasambandamoorthy V et al.. “Age-Adjusted D-Dimer Cutoff Levels to Rule Out Deep Vein Thrombosis.” JAMA (2026). PMID: 41490105 ↗
L2bTRIAL_NONRANDOMCited in: History and Physical Examination - [103]
Kang T, Han S, Lu YL et al.. “Artificial intelligence risk stratification from dynamic digital subtraction angiography radiomics predicts pulmonary embolism and associates with clinical outcomes in deep vein thrombosis: A retrospective cohort study.” Journal of vascular surgery. Venous and lymphatic disorders (2026). PMID: 41638306 ↗
L2bCOHORTCited in: History and Physical Examination - [104]
Simard C, Le Gal G, Lazo-Langner A et al.. “Association Between Bariatric Surgery and the Long-Term Risk for Venous Thromboembolism: A Population-Based Matched Cohort Study.” American journal of hematology (2026). PMID: 41588795 ↗
L2bCOHORTCited in: History and Physical Examination - [105]
Klimitz FJ, Knoedler S, Fabi A et al.. “Weighing the Risk: The Impact of Obesity on 30-Day Complications After Cosmetic Abdominoplasty-An Observational Cohort Study of 1,778 Cases.” Aesthetic plastic surgery (2026). PMID: 41201611 ↗
L2bCOHORTCited in: History and Physical Examination - [106]
Ye Y, Mahati S, Aihemaiti W et al.. “A postpartum-adapted algorithm for safe management of suspected pulmonary embolism: a retrospective cohort study.” American journal of obstetrics and gynecology (2026). PMID: 41183725 ↗
L2bCOHORTCited in: History and Physical Examination - [107]
. “[Guidelines for the management of cerebral venous thrombosis during pregnancy and the puerperium (2025 edition)].” Zhonghua yi xue za zhi (2025). PMID: 41145272 ↗
L1cGUIDELINECited in: History and Physical Examination - [108]
Abbattista M, Truma A, Martinelli I et al.. “The risk of cerebral vein thrombosis associated with different types of combined hormonal contraceptives: a case-control study.” Journal of thrombosis and haemostasis : JTH (2025). PMID: 40617503 ↗
L3bCASE_CONTROLCited in: History and Physical Examination - [109]
Li S, Wang M, Xu Y. “Predictors of pulmonary infarction in pediatric pulmonary embolism: A retrospective cohort study.” Thrombosis research (2025). PMID: 41086550 ↗
L2bCOHORTCited in: History and Physical Examination - [110]
Ajrawat P, Price B, Gooch D et al.. “Assessing Postoperative Pain in Patients Who Underwent Total Knee Arthroplasty Using an Automated Self-Logging Patient-Reported Outcome Measure Collection Device: Retrospective Cohort Study.” JMIR human factors (2025). PMID: 40638842 ↗
L2bCOHORTCited in: History and Physical Examination - [111]
Ren Y, Liu R. “Prevalence and risk factors of deep vein thrombosis in elderly: a systematic review and meta-analysis.” Open medicine (Warsaw, Poland) (2026). PMID: 41726136 ↗
L2aSR_OBSCited in: History and Physical Examination - [112]
Kargar-Soleimanabad S, Najafi S, Ahmadi M et al.. “Diagnostic value of the wells score for lower extremity deep vein thrombosis in hospitalized patients: A case-control study.” Phlebology (2026). PMID: 41489509 ↗
L3bCASE_CONTROLCited in: History and Physical Examination - [113]
Zhao Y, Zhou T, Fang Q et al.. “Short-term outcomes after hybrid unicompartmental knee arthroplasty: A retrospective cohort study with minimum 3-year follow-up.” Medicine (2026). PMID: 41861224 ↗
L2bCOHORTCited in: History and Physical Examination, Diagnosis and Workup - [114]
Benseler A, Gien LT, Swift B et al.. “Association of body mass index and length of stay in patients undergoing minimally invasive surgery for uterine cancer: a National Surgical Quality Improvement Program (NSQIP) study.” International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2026). PMID: 41774951 ↗
L5OTHERCited in: History and Physical Examination, Diagnosis and Workup, Special Populations - [115]
Kulachote N, Phoophiboon P, Chanplakorn P et al.. “Risk Factors for Preoperative DVT in Elderly Patients with Hip Fractures.” Journal of clinical medicine (2026). PMID: 41753171 ↗
L5OTHERCited in: History and Physical Examination - [116]
Fu C, Chen J, Shen Z et al.. “Plasma Protein Mediation of the Association Between Blood Pressure and Retinal Vascular Occlusion.” Translational vision science & technology (2025). PMID: 41324311 ↗
L5OTHERCited in: History and Physical Examination - [117]
Smadi Z, Lingam S, Muwalla R et al.. “Weight on the fixation: the influence of body mass index on lower extremity fracture fixation outcomes.” Injury (2025). PMID: 41197500 ↗
L5OTHERCited in: History and Physical Examination - [118]
Xu JJ, Johnson MC, Lama G et al.. “The Effect of Body Mass Index on the Efficacy of Semaglutide Use at the Time of Total Knee Arthroplasty.” The Journal of arthroplasty (2026). PMID: 41072554 ↗
L5OTHERCited in: History and Physical Examination - [119]
Akar B, Oztürkmen Y, Balioglu MB et al.. “The Effect of Obesity on Simultaneous Bilateral Knee Arthroplasty Surgery.” Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews (2025). PMID: 40981512 ↗
L5OTHERCited in: History and Physical Examination - [120]
Hoedemakers T, van Hattum ES, Petri BJ et al.. “Upper extremity post-thrombotic syndrome score: consensus results from an international Delphi study.” Journal of thrombosis and haemostasis : JTH (2025). PMID: 40973017 ↗
L5OTHERCited in: History and Physical Examination - [121]
O'Connor B, Meister K, Fellner A et al.. “Analyzing the Adequacy of BMI-Tiered Enoxaparin Dosing for Venous Thromboembolism Prophylaxis in the Bariatric Surgery Population Based on Anti-Factor Xa Assay Data.” Obesity surgery (2025). PMID: 40615759 ↗
L5OTHERCited in: History and Physical Examination - [122]
Canas A, Epstein J, Chen T et al.. “Diagnosis of Venous Thromboembolism.” The Medical clinics of North America (2025). PMID: 40500082 ↗
L5REVIEW_NARRATIVECited in: History and Physical Examination - [123]
Jin C, Hu Y, Liu F. “Clinical characteristics, clinical laboratories, and risk factors of elderly patients with chronic obstructive pulmonary disease complicated with pulmonary embolism.” Frontiers in medicine (2025). PMID: 40438367 ↗
L5OTHERCited in: History and Physical Examination - [124]
Kumar S, Nasef H, Yates Z et al.. “Association of Body Mass Index With Severe Sepsis Outcomes in Critically-Ill Severely Injured Adult Trauma Patients: A National Analysis.” The Journal of surgical research (2025). PMID: 40378666 ↗
L5OTHERCited in: History and Physical Examination - [125]
Cherkaoui M, Al-Attabi M, Salimi S et al.. “Proximal venous ultrasound with risk stratification safely excludes deep venous thrombosis in emergency department routine care: an observational study.” Scandinavian journal of trauma, resuscitation and emergency medicine (2025). PMID: 40369661 ↗
L5OTHERCited in: History and Physical Examination - [126]
Masuda Y, Konishi T, Yakushijin Y et al.. “Impact of body mass index on D-dimer diagnostic utility for deep vein thrombosis in patients with cancer: a single-center retrospective analysis.” International journal of clinical oncology (2025). PMID: 40355784 ↗
L5OTHERCited in: History and Physical Examination - [127]
Daher M, Liu J, Smith N et al.. “Short-term outcomes of outpatient total joint arthroplasty in morbidly obese patients.” European journal of orthopaedic surgery & traumatology : orthopedie traumatologie (2025). PMID: 40349255 ↗
L5OTHERCited in: History and Physical Examination - [128]
Waseem MH, Abideen ZU, Rissardo JP et al.. “Comparing Efficacy and Safety of Different Anticoagulants in Cerebral Venous Thrombosis: A Systematic Review and Network Meta-Analysis.” Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis (2026). PMID: 41773593 ↗
L2aSR_OBSCited in: Diagnosis and Workup - [129]
Schmidt C, Papo M, Taïeb D et al.. “Severe thrombocytopenia in antiphospholipid syndrome: a retrospective study of 432 patients.” RMD open (2026). PMID: 41956709 ↗
L2bCOHORTCited in: Diagnosis and Workup, Special Populations - [130]
Huang J, Lin P, Wang L et al.. “Case Report: Primary vascular sarcoma presenting as massive pulmonary embolism salvaged by veno-arterial extracorporeal membrane oxygenation and interventional therapy.” Frontiers in cardiovascular medicine (2026). PMID: 41940087 ↗
L4CASE_REPORTCited in: Diagnosis and Workup - [131]
Mo R, Yu S, Xu H et al.. “Upadacitinib in refractory ulcerative colitis patients with high thromboembolic risk: two case reports.” Frontiers in immunology (2026). PMID: 41853288 ↗
L4CASE_REPORTCited in: Diagnosis and Workup - [132]
Hu H, Cai D, Li J et al.. “Pulmonary infection by Nocardia saintgeorgesii mimicking lung cancer with concurrent pulmonary embolism in an immunocompetent host: a case highlighting the diagnostic role of mNGS.” Frontiers in cellular and infection microbiology (2026). PMID: 41822328 ↗
L4CASE_REPORTCited in: Diagnosis and Workup, Differential Diagnosis, Special Populations - [133]
Xu C, Annapureddy H, Carson L et al.. “Impact of a factor Xa inhibitor (apixaban) on SIV pathogenesis and response to antiretroviral therapy.” JCI insight (2026). PMID: 41948932 ↗
L5OTHERCited in: Diagnosis and Workup - [134]
Mukund A, Thakur V, Jindal A et al.. “Long-Term Efficacy and Outcomes of Endovascular Interventions in Budd-Chiari Syndrome-A Real World Analysis.” Liver international : official journal of the International Association for the Study of the Liver (2026). PMID: 41947698 ↗
L5OTHERCited in: Diagnosis and Workup - [135]
Terao R, Fujino R, Hayashi K et al.. “Role of Autotaxin in the Pathogenesis of Retina Ischemia and Its Therapeutic Implications.” International journal of molecular sciences (2026). PMID: 41898636 ↗
L5OTHERCited in: Diagnosis and Workup - [136]
Deng Y, Liu Y, Li X et al.. “Delayed anti-vascular endothelial growth factor therapy in patients with type 2 diabetes mellitus and branch retinal vein occlusion-associated macular edema negatively affects visual outcomes.” Frontiers in endocrinology (2026). PMID: 41884213 ↗
L5OTHERCited in: Diagnosis and Workup - [137]
Zhan J, Qiao D, Sun G et al.. “Geometric Decomposition of OCT Angiography in RVO: Unmasking Congestive Versus Compensatory Phenotypes and Deep Retina-Choroid Coupling.” Translational vision science & technology (2026). PMID: 41873904 ↗
L5OTHERCited in: Diagnosis and Workup - [138]
Jia J, Ning C, Wang Q et al.. “Stereotactic body radiotherapy plus lenvatinib and sintilimab with and without transarterial embolization for advanced hepatocellular carcinoma with portal vein tumor thrombus: a dual-center, propensity score-matched retrospective analysis.” Frontiers in immunology (2026). PMID: 41859127 ↗
L5OTHERCited in: Diagnosis and Workup, Special Populations - [139]
Iby J, Kreminger J, Stino H et al.. “Retinal Characteristics in Eyes With Retinal Vein Occlusion Using Widefield Swept-Source Optical Coherence Tomography Angiography.” Investigative ophthalmology & visual science (2026). PMID: 41854209 ↗
L5OTHERCited in: Diagnosis and Workup - [140]
Hofstetter RV, Marx CE, Kraaijpoel N et al.. “Reporting of D-dimer testing in venous thromboembolism diagnostic management studies: a scoping review.” Journal of thrombosis and haemostasis : JTH (2026). PMID: 41839295 ↗
L5REVIEW_NARRATIVECited in: Diagnosis and Workup - [141]
Cun D, Li J, He P et al.. “Preoperative deep vein thrombosis in tibial plateau fractures: development and internal validation of an interpretable multivariable machine-learning diagnostic model.” Frontiers in medicine (2026). PMID: 41767515 ↗
L5OTHERCited in: Diagnosis and Workup - [142]
Wu CL, Lu JW, Ho YJ et al.. “Deep Immunophenotyping Reveals a Resilient Tph-ABC Axis in Difficult-to-treat Rheumatoid Arthritis: A Case Report of JAK Inhibitor Failure Complicated by Herpes Zoster and Thrombosis.” In vivo (Athens, Greece) (2026). PMID: 41760293 ↗
L4CASE_REPORTCited in: Diagnosis and Workup - [143]
Ezeh UC, Tesema N, Hasnie S et al.. “Isolated external jugular thrombophlebitis secondary to acute pharyngitis: a case report and a review of the literature.” Italian journal of pediatrics (2024). PMID: 39285285 ↗
L4CASE_REPORTCited in: Differential Diagnosis - [144]
Knight GM, Desai KR. “Team-based approach to deep venous disease: A multidisciplinary approach to the multifaceted problem of thrombotic lower extremity venous disease.” Seminars in vascular surgery (2025). PMID: 41386912 ↗
L5REVIEW_NARRATIVECited in: Differential Diagnosis - [145]
Phuyal D, Abbas F, Darras O et al.. “Evaluating the Safety of Immediate Lymphatic Reconstruction With Implant-Based Breast Reconstruction: Eight-Year Institutional Review.” Microsurgery (2025). PMID: 40956145 ↗
L5REVIEW_NARRATIVECited in: Differential Diagnosis - [146]
Hassanzadeh S, Lakhman Y, Sadowski EA et al.. “Abdominopelvic complications of gynecologic malignancy: Essentials for radiologists.” European journal of radiology (2025). PMID: 40753689 ↗
L5REVIEW_NARRATIVECited in: Differential Diagnosis - [147]
Hurst M, Shin L. “Charcot neuroarthropathy: Surgical and conservative treatment approaches.” Seminars in vascular surgery (2025). PMID: 40086925 ↗
L5REVIEW_NARRATIVECited in: Differential Diagnosis - [148]
Wen X, Wu Z. “A retrospective study on the diagnostic value of ultrasonography for primary vascular leiomyosarcoma misdiagnosed as deep vein thrombosis.” Phlebology (2026). PMID: 40454675 ↗
L2bCOHORTCited in: Differential Diagnosis - [149]
Mitchell S, Rojas OG, Mathavan A et al.. “A 36-Year-Old Man With Hemoptysis and Fevers.” Chest (2026). PMID: 41672657 ↗
L4CASE_REPORTCited in: Differential Diagnosis - [150]
Lesage L, Barral PA, Chew A et al.. “Streptococcus constellatus-associated Lemierre syndrome complicated by pulmonary artery pseudoaneurysm in an 11-year-old girl.” Pediatric radiology (2026). PMID: 41511544 ↗
L4CASE_REPORTCited in: Differential Diagnosis - [151]
Ossuna M, Hamamoto Filho PT, Zanini MA. “Spontaneous thrombosis of drainage vein in cavernoma-associated developmental venous anomaly.” Neuroradiology (2025). PMID: 41065868 ↗
L4CASE_REPORTCited in: Differential Diagnosis - [152]
DSouza R, Kuruvilla Thomas S, Patharateeranart K et al.. “Pseudo hepatic vein thrombosis in a newborn with infracardiac total anomalous pulmonary venous connection.” Pediatric radiology (2024). PMID: 39485501 ↗
L4CASE_REPORTCited in: Differential Diagnosis - [153]
Godoy IRB, Cantarelli Rodrigues T, Alharfi M et al.. “Imaging in the diagnosis and characterization of tennis leg.” Skeletal radiology (2026). PMID: 41981329 ↗
L5REVIEW_NARRATIVECited in: Differential Diagnosis - [154]
Embaby O, Bin Asmadi A, Binte Asmadi A et al.. “PATHOGENESIS OF ACUTE DIABETIC CHARCOT ARTHROPATHY IN THE FOOT AND ANKLE: A COMPREHENSIVE LITERATURE REVIEW.” Orthopedic reviews (2025). PMID: 40969400 ↗
L5REVIEW_NARRATIVECited in: Differential Diagnosis - [155]
Jang E, Moon KY, Park SC et al.. “Primary leiomyosarcoma originating from the deep femoral vein initially presenting as chronic deep vein thrombosis: A case report and review of literature.” Medicine (2026). PMID: 41961719 ↗
L4CASE_REPORTCited in: Differential Diagnosis, Special Populations - [156]
Cheng L, Li L. “Tumor-like cortical venous thrombosis: Case report and literature review.” Medicine (2026). PMID: 41766497 ↗
L4CASE_REPORTCited in: Differential Diagnosis, Special Populations - [157]
Ak S, Thomas-Ogunniyi J, Takei H. “Intravascular Fasciitis Mimicking Deep Vein Thrombosis with Pulmonary Embolism in May-Thurner Syndrome: First Reported Case with Literature Review.” Annals of clinical and laboratory science (2025). PMID: 40962462 ↗
L4CASE_REPORTCited in: Differential Diagnosis - [158]
Teshima R, Saito-Sasaki N, Sawada Y. “Age as a key risk factor for deep vein thrombosis in patients with lower limb cellulitis.” Frontiers in medicine (2025). PMID: 40620438 ↗
L5OTHERCited in: Differential Diagnosis - [159]
Cleary CM, Orosco E, Gallagher J et al.. “Continuation of anticoagulation through ambulatory phlebectomy does not impact postoperative bleeding risk.” Journal of vascular surgery. Venous and lymphatic disorders (2025). PMID: 39890080 ↗
L5OTHERCited in: Differential Diagnosis - [160]
Awashra A, Salameh AA, Milhem F et al.. “Right atrial thrombus mimicking cardiac myxoma: surgical and postoperative management.” Journal of cardiothoracic surgery (2025). PMID: 41422031 ↗
L4CASE_REPORTCited in: Differential Diagnosis - [161]
Phillips I, Chen J, Milhem M et al.. “Vascular Leiomyosarcoma Masquerading as Chronic Deep Venous Thrombosis.” Clinical nuclear medicine (2026). PMID: 41380714 ↗
L4CASE_REPORTCited in: Differential Diagnosis - [162]
Romano A, Kaisari E, Belkoniene M et al.. “A case of paracentral acute middle maculopathy and retinal vein occlusion: idiopathic occlusive retinal vasculitis or incomplete Behçet's disease?” BMC ophthalmology (2025). PMID: 41088010 ↗
L4CASE_REPORTCited in: Differential Diagnosis - [163]
Bass R, Mitta P, Burgan C et al.. “Intravascular organizing thrombus in the forearm: a unique imaging presentation.” Skeletal radiology (2026). PMID: 41068310 ↗
L4CASE_REPORTCited in: Differential Diagnosis - [164]
Tse JD, Laller S, Kharait S. “Case Report: Steroids for diabetic myonecrosis in ESKD: an unconventional treatment with unexpected success.” Frontiers in nephrology (2025). PMID: 40963896 ↗
L4CASE_REPORTCited in: Differential Diagnosis - [165]
Al-Akhali ES, Alshoabi SA, Muslem HF et al.. “Multisystemic Tuberculosis Masquerading as Aggressive Cardiac Tumor Causing Budd-Chiari Syndrome Disseminated to the Brain Resulting in Death of a Six-Year-Old Boy.” Pathogens (Basel, Switzerland) (2025). PMID: 40872282 ↗
L4CASE_REPORTCited in: Differential Diagnosis - [166]
Okumura M, Sakuta K, Gomi T et al.. “Atypical intracerebral hemorrhage and internal jugular vein thrombosis in meningovascular neurosyphilis.” Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy (2025). PMID: 40633667 ↗
L4CASE_REPORTCited in: Differential Diagnosis - [167]
Erb BM, Jeffrey JH, Reed DS et al.. “MRSA Cellulitis with Orbital and Retinal Abscesses Resulting in Lemierre Syndrome Following Eyebrow Piercing.” Ophthalmic plastic and reconstructive surgery (Unknown). PMID: 39718131 ↗
L4CASE_REPORTCited in: Differential Diagnosis - [168]
Reich T, Blum B, Zimmerli L. “[The slightly different neck pain].” Praxis (2026). PMID: 41784513 ↗
L4CASE_REPORTCited in: Differential Diagnosis - [169]
Gietzelt C, Wiedemann J, Lappas A et al.. “[Thrombosis of the superior ophthalmic vein-A case series and review of the literature].” Die Ophthalmologie (2024). PMID: 39266751 ↗
L4CASE_REPORTCited in: Differential Diagnosis - [170]
Duan H, Jiang C, Zhang B et al.. “Risk of Malignancies and Major Adverse Cardiovascular Events Related to JAK Inhibitors in Rheumatoid Arthritis: A Meta-Analysis.” Clinical pharmacology and therapeutics (2026). PMID: 41427516 ↗
L2aSR_OBSCited in: Special Populations - [171]
Chen K, Zhuo L, Liu Z et al.. “Presurgical molecular therapy for renal cell carcinoma with venous tumor thrombus: a systematic review and meta-analysis.” Frontiers in immunology (2025). PMID: 41394875 ↗
L2aSR_OBSCited in: Special Populations - [172]
Willems RAL, van Diepen AE, Dekker EN et al.. “Thromboembolic Events During Perioperative Therapy for Resectable and Borderline Resectable Pancreatic Cancer in the PREOPANC-2 Trial.” Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2026). PMID: 41610374 ↗
L1bRCTCited in: Special Populations - [173]
Mahé I, Chapelle C, Girard P et al.. “Predictors of clinically relevant bleeding during extended anticoagulation for cancer-associated venous thromboembolism (API-CAT): a post-hoc analysis of a randomised, non-inferiority trial.” The Lancet. Haematology (2026). PMID: 41365312 ↗
L1bRCTCited in: Special Populations - [174]
Mo N, Hu K, Zeng Z et al.. “Stereotactic body radiation therapy combined with cadonilimab and lenvatinib in the treatment of hepatocellular carcinoma with Vp3 or Vp4 portal vein tumor thrombus: a prospective, multicenter, single-arm, phase II clinical trial.” Frontiers in immunology (2025). PMID: 41293180 ↗
L2bTRIAL_NONRANDOMCited in: Special Populations - [175]
Tong CX, Ma R, Meng T. “Left ovarian vein thrombosis suspected during cesarean section and confirmed postoperatively: a case report and review of the literature.” BMC pregnancy and childbirth (2026). PMID: 41688956 ↗
L4CASE_REPORTCited in: Special Populations - [176]
Yaqian Y, Chuanliang Z, Guowei Z et al.. “Efficacy of Z-shaped supine position in robot-assisted radical prostatectomy: study protocol for a randomized controlled trial.” Trials (2026). PMID: 41588472 ↗
L2bTRIAL_NONRANDOMCited in: Special Populations - [177]
Jian H, Cui X, Dou Y et al.. “Adoption of plasma D-dimer testing, color Doppler ultrasound, and enoxaparin sodium in predicting and preventing lower extremity deep vein thrombosis in high-risk parturients undergoing cesarean section.” Medicine (2025). PMID: 41398758 ↗
L1bRCTCited in: Special Populations - [178]
Federspiel JJ, Rodger MA, Hoffman MR et al.. “Postoperative venous thromboembolism following cesarean delivery: prevalence, pathophysiology, diagnosis, treatment, and prevention.” American journal of obstetrics and gynecology (2026). PMID: 41485833 ↗
L5REVIEW_NARRATIVECited in: Special Populations - [179]
Ma J, Ke X, Zhu D. “The effect of anticoagulants on preventing venous thromboembolism in cancer patients: A systematic review and meta-analysis.” The National medical journal of India (2025). PMID: 41645951 ↗
L2aSR_OBSCited in: Special Populations - [180]
Wardhana DPW, Soetomo CT, Satyarsa ABS et al.. “Critical shift phase in deep vein thrombosis development after major sellar region tumor surgeries: a systematic review.” Annals of medicine (2025). PMID: 41392925 ↗
L2aSR_OBSCited in: Special Populations - [181]
Chiu YC, Chang WC, Chiu YC. “Early catheter-directed portal vein thrombolysis in myeloproliferative disorder-related diffuse mesenteric venous ischemia: A case report.” World journal of gastroenterology (2026). PMID: 41640868 ↗
L4CASE_REPORTCited in: Special Populations - [182]
Darby A, Bocchicchio M, Tabatabai R. “Cerebral Venous Thrombosis.” Emergency medicine clinics of North America (2026). PMID: 41260855 ↗
L5REVIEW_NARRATIVECited in: Special Populations - [183]
Guo B, Yerken S, Luo C et al.. “Liver resection versus transarterial chemoembolization plus PD-1 inhibitors and lenvatinib for hepatocellular carcinoma with portal vein tumour thrombus.” BJS open (2025). PMID: 41871372 ↗
L5OTHERCited in: Special Populations - [184]
Wang L, Feng JK, Zhou B et al.. “Optimal duration of adjuvant targeted-immunotherapy in patients with initially unresectable hepatocellular carcinoma with portal vein tumor thrombus following successful conversion therapy.” The oncologist (2026). PMID: 41723827 ↗
L5OTHERCited in: Special Populations - [185]
Xie R, Lu M, Wu J et al.. “Renal Pelvic Urothelial Carcinoma With Venous Tumor Thrombus: Prognosis and Reconsideration of TNM Staging.” Clinical genitourinary cancer (2026). PMID: 41680068 ↗
L5OTHERCited in: Special Populations - [186]
Mohan N, Srivastava SK, Duphare C et al.. “Risk of retinal vein occlusions in patients taking systemic tyrosine kinase inhibitors.” Eye (London, England) (2026). PMID: 41652018 ↗
L5OTHERCited in: Special Populations - [187]
Kurita D, Miyamoto S, Saito Y et al.. “Prevalence of Subclinical Internal Jugular Vein Thrombosis After Microvascular Head and Neck Reconstruction.” Microsurgery (2026). PMID: 41575013 ↗
L5OTHERCited in: Special Populations - [188]
Zhou B, Ma Z, Wang L et al.. “Real-world outcomes of stereotactic body radiotherapy plus sintilimab and bevacizumab for hepatocellular carcinoma with portal vein tumor thrombus.” The oncologist (2026). PMID: 41495001 ↗
L5OTHERCited in: Special Populations - [189]
Cui S, Wang D, Lyu S et al.. “Organ-specific role of neutrophil extracellular traps in shaping the postoperative thrombo-inflammatory niche in pancreatic ductal adenocarcinoma: a multi-model machine learning and mechanistic study.” Frontiers in immunology (2025). PMID: 41445740 ↗
L5OTHERCited in: Special Populations - [190]
Yayac M, Konen T, Parvizi J. “The Use of Intermittent Pneumatic Compression in Orthopaedic Surgery: An Umbrella Review and Meta-Analysis.” JB & JS open access (2026). PMID: 42428035 ↗
L1aCited in: Epidemiology and Risk Factors - [191]
Potere N, Bertù L, Bucherini E et al.. “Incidence and predictors of recurrent venous thromboembolism after isolated distal deep vein thrombosis: a post-hoc analysis of the RIDTS trial.” Haematologica (2026). PMID: 42389836 ↗
L1bCited in: Epidemiology and Risk Factors - [192]
Ding T, Chen Y, Huang M et al.. “Meta-analysis of the effectiveness of ankle pump exercise combined with anticoagulant therapy for the prevention of post-operative lower extremity deep vein thrombosis.” Frontiers in neurology (2026). PMID: 42523846 ↗
L1aCited in: Epidemiology and Risk Factors - [193]
Qin L, Ye LJ, Liang P et al.. “Risk of venous thromboembolism with upadacitinib in rheumatoid arthritis: a meta-analysis.” Journal of thrombosis and thrombolysis (2026). PMID: 42509494 ↗
L1aCited in: Epidemiology and Risk Factors - [194]
Camporese G, Bernardi E, Bortoluzzi C et al.. “Mesoglycan for long-term secondary prevention in patients with superficial vein thrombosis (METRO): a multicentre randomised clinical trial in Italy.” EClinicalMedicine (2026). PMID: 42534458 ↗
L2bCited in: Epidemiology and Risk Factors - [195]
Deng X, Wan J, Huang X et al.. “Predictive model for preoperative deep vein thrombosis in distal femur fractures using inflammatory blood markers: a single-center retrospective cohort study.” PeerJ (2026). PMID: 42504248 ↗
L1bCited in: Epidemiology and Risk Factors - [196]
Tian Y, Qi M, Wang Q et al.. “Implementation of a nine-grid thinking model to optimize operating room nursing pathways for older adults undergoing total knee arthroplasty.” Journal of orthopaedic surgery (Hong Kong) (2026). PMID: 42375121 ↗
L1bCited in: Epidemiology and Risk Factors - [197]
Cortez E, Torres Luna E, Blancerte Ibarra M et al.. “Risk of venous thromboembolism with CDK4/6 inhibitor use in breast cancer: a systematic review and meta-analysis.” The oncologist (2026). PMID: 42438148 ↗
L2aCited in: Epidemiology and Risk Factors - [198]
Endara-Mina J, Escudero CJ, Intriago C et al.. “Associated thromboembolic events to the post COVID syndrome: a systematic review and meta-analysis.” Frontiers in cardiovascular medicine (2026). PMID: 42368852 ↗
L2aCited in: Epidemiology and Risk Factors - [199]
Tummala S, Mittal MM, Sambandam SN et al.. “Differential complication risks in diabetic and non-diabetic geriatric patients following distal femur fracture surgery.” European journal of orthopaedic surgery & traumatology : orthopedie traumatologie (2026). PMID: 42550286 ↗
L2bCited in: Epidemiology and Risk Factors - [200]
Wang Y, Zhang B, Guo H et al.. “Operative Duration as an Independent Risk Factor for Lower-Extremity Deep Vein Thrombosis Following Shoulder Arthroscopy: A Prospective Cohort Study With Systematic Ultrasonographic Screening.” Orthopaedic journal of sports medicine (2026). PMID: 42453309 ↗
L2bCited in: Epidemiology and Risk Factors - [201]
Parmar T, Adio A, Handy A et al.. “Tranexamic acid in high-risk shoulder arthroplasty patients: safety across thromboembolic, cardiac, renal, and neurologic risk profiles.” Archives of orthopaedic and trauma surgery (2026). PMID: 42397605 ↗
L2bCited in: Epidemiology and Risk Factors - [202]
Xing Y, Cai W, Wang L et al.. “Risk Prediction Models for Deep Vein Thrombosis in Patients With Spontaneous Intracerebral Hemorrhage: A Systematic Review and Meta-Analysis.” Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis (2026). PMID: 42383743 ↗
L2aCited in: Epidemiology and Risk Factors - [203]
Xie D, Cao G, Chen R et al.. “Early ambulation within 24 h after joint arthroplasty: a retrospective cohort study.” Frontiers in medicine (2026). PMID: 42568406 ↗
L3bCited in: Epidemiology and Risk Factors - [204]
Brindl N, Chandrakumaran K, Shah N et al.. “Deep vein thrombosis and pulmonary embolism following cytoreductive surgery and HIPEC for PMP of appendiceal origin.” European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology (2026). PMID: 42566936 ↗
L3bCited in: Epidemiology and Risk Factors - [205]
Park YU, Jun J, Sakong S et al.. “Challenging the Role of Routine Thromboprophylaxis in Foot and Ankle Surgery: A Comparative Study of Aspirin, Enoxaparin, and No Prophylaxis.” Clinics in orthopedic surgery (2026). PMID: 42558185 ↗
L4Cited in: Epidemiology and Risk Factors - [206]
Puetz J, Salas J. “The Combined Effect of Obesity and Contraceptive Use on Pulmonary Embolism in Adolescent Females Residing in the United States.” Pediatric blood & cancer (2026). PMID: 42527845 ↗
L3bCited in: Epidemiology and Risk Factors - [207]
Azulay AA, Stein M, Tabo LY et al.. “High-velocity gunshot chest trauma: tailoring patient care through insights from a mass casualty experience.” European journal of trauma and emergency surgery : official publication of the European Trauma Society (2026). PMID: 42525108 ↗
L4Cited in: Epidemiology and Risk Factors - [208]
Areti AS, Hafeez H, Sangineni PV et al.. “Elevated risk of wound and systemic complications in MRSA-colonized patients undergoing lower extremity orthopedic trauma surgery.” European journal of trauma and emergency surgery : official publication of the European Trauma Society (2026). PMID: 42507131 ↗
L3bCited in: Epidemiology and Risk Factors - [209]
Wu X, Wu X, Xiong J et al.. “Peripherally inserted central catheters versus central venous catheters in critically ill patients under standardized insertion protocols: a propensity score-matched cohort study.” BMC anesthesiology (2026). PMID: 42481958 ↗
L3bCited in: Epidemiology and Risk Factors - [210]
Wang L, Luo Z, Yang L et al.. “The Effectiveness and Safety of Rivaroxaban and Edoxaban in the Treatment of Lower Extremity Deep Vein Thrombosis.” Annals of vascular surgery (2024). PMID: 38960092 ↗
L3bCited in: Etiology and Triggering Factors - [211]
Vesa ŞC, Chira R, Vlaicu SI et al.. “Systemic and Local Factors' Influence on the Topological Differences in Deep Vein Thrombosis.” Medicina (Kaunas, Lithuania) (2019). PMID: 31623212 ↗
L3bCited in: Etiology and Triggering Factors - [212]
Kraft C, Schuettfort G, Weil Y et al.. “Thrombosis of the inferior vena cava and malignant disease.” Thrombosis research (2014). PMID: 25081831 ↗
L4Cited in: Etiology and Triggering Factors - [213]
Yang Z, Qin J. “Epidemiological patterns and risk profiling of hospital acquired venous thromboembolism in a tertiary medical center in eastern China: a retrospective cohort study (2023-2024).” Frontiers in cardiovascular medicine (2026). PMID: 42459186 ↗
L3bCited in: Pathophysiology - [214]
Lytle JR, Miller AE, Martin DS et al.. “Jugular venous flow dynamics during acute weightlessness and partial gravity in parabolic flight.” Journal of applied physiology (Bethesda, Md. : 1985) (2026). PMID: 41770529 ↗
L4Cited in: Pathophysiology - [215]
Toprak Ş, Albayrak M. “Prolonged Immobility Due to Digital Exposure: A Rising Risk of E-Thrombosis in the Digital Age.” Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis (2026). PMID: 41733924 ↗
L4Cited in: Pathophysiology - [216]
Shinozaki A, Yamamoto T, Kurata A. “Incidence and clinicopathological analysis of portal vein and inferior vena cava thrombosis in autopsy cases of autosomal dominant polycystic kidney disease.” Clinical and experimental nephrology (2026). PMID: 41649706 ↗
L4Cited in: Pathophysiology - [217]
Erdağ M, Aktaş K, Canleblebici M et al.. “Assessment of corneal endothelial morphology in retinal vein occlusion.” BMC ophthalmology (2026). PMID: 41622189 ↗
L3bCited in: Pathophysiology - [218]
Wu S, Jia W, Hua J et al.. “Systemic Exposure and Multicomponent Pharmacokinetics of Mailuoning Oral Liquid: Integrated Ultra-High-Performance Liquid Chromatography-High-Resolution Mass Spectrometry Profiling and Ultra-High-Performance Liquid Chromatography-Tandem Mass Spectrometry Quantification.” Journal of separation science (2026). PMID: 42429384 ↗
L1bCited in: Pathophysiology - [219]
Pellerito M, Dowling AR, Luke CE et al.. “Monocyte depletion reduces late experimental post-thrombotic fibrotic injury in a stasis mouse model.” Thrombosis research (2026). PMID: 41610828 ↗
L3bCited in: Pathophysiology - [220]
Thi Nguyen KT, Tran LCD, Van Nguyen T. “Nurse-led education to improve deep vein thrombosis prevention knowledge after hip arthroplasty: a sequential controlled quasi-experimental study.” International journal of orthopaedic and trauma nursing (2026). PMID: 42570556 ↗
L2bCited in: Pathophysiology - [221]
Vojinovic T, Askling J, Antovic A. “The risk of venous thromboembolism in RA.” Rheumatology (Oxford, England) (2026). PMID: 42502986 ↗
L5Cited in: Pathophysiology - [222]
Moy BM, Barajas R, Savino C et al.. “Venous Thromboembolism Following Endoscopic Sleeve Gastroplasty.” Gastrointestinal endoscopy (2026). PMID: 42413834 ↗
L5Cited in: Pathophysiology - [223]
Yin J, Zhu E, Zheng X et al.. “Immune drivers of venous thrombosis: orchestrating initiation, formation, and resolution within the hypoxic microenvironment.” Frontiers in immunology (2026). PMID: 42358987 ↗
L5Cited in: Pathophysiology - [224]
Bhopal AS, Luo Y, Grover LM et al.. “Preclinical Models of Venous Thrombosis: A Critical Appraisal for Translational Research.” Arteriosclerosis, thrombosis, and vascular biology (2026). PMID: 42341088 ↗
L5Cited in: Pathophysiology - [225]
Balog Virág K, Csikós P, Raska A et al.. “Cell-dependent antithrombotic effect of tranexamic acid.” Frontiers in immunology (2026). PMID: 42273679 ↗
L5Cited in: Pathophysiology - [226]
Liang Y, Deng X, Chen M et al.. “Direct randomized evidence comparing ranibizumab and bevacizumab for macular edema secondary to retinal vein occlusion: a systematic review and meta-analysis.” BMC ophthalmology (2026). PMID: 42533334 ↗
L1aCited in: Diagnosis and Workup - [227]
Barco S, Wolf S, Sebastian T et al.. “Quality of life and functional recovery after venous stent placement for postthrombotic syndrome: insights from the ARIVA multinational randomized trial.” Research and practice in thrombosis and haemostasis (2026). PMID: 42568863 ↗
L1bCited in: Diagnosis and Workup - [228]
Zhang X, Geng W, Wei L et al.. “Risk factors and intervention strategies for lower extremity deep vein thrombosis after intravenous thrombolysis for acute ischemic stroke.” Frontiers in cardiovascular medicine (2026). PMID: 42483456 ↗
L2bCited in: Diagnosis and Workup - [229]
Liu Y, Zhang T, Zhang L et al.. “Effectiveness of comprehensive nursing care combined with an intermittent pneumatic compression device for preventing lower extremity venous thrombosis in long-term bedridden elderly patients: A prospective controlled study.” Medicine (2026). PMID: 42363552 ↗
L1bCited in: Diagnosis and Workup - [230]
Ding X, Wu H, Huang Q. “Diagnostic value of D-dimer in screening for deep vein thrombosis after total joint arthroplasty: a meta-analysis.” Frontiers in surgery (2026). PMID: 42523683 ↗
L2aCited in: Diagnosis and Workup - [231]
Yu J, Guo T, Hu W et al.. “Development and internal-external validation of a nomogram model for lower extremity deep vein thrombosis in patients after ruptured intracranial aneurysm surgery based on dynamic D-dimer trajectory.” International journal of medical informatics (2026). PMID: 42531668 ↗
L3bCited in: Diagnosis and Workup - [232]
Shi C, Peng C, Song J et al.. “Efficacy and safety of cytoreductive nephrectomy combined with thrombectomy in metastatic renal cell carcinoma with venous tumor thrombus: a real-world study based on inverse probability of treatment weighting.” World journal of urology (2026). PMID: 42472396 ↗
L3bCited in: Diagnosis and Workup - [233]
Yigit N, Arguner H, Ulutas F et al.. “Pulmonary artery involvement in Behçet's disease patients: real-life data on aneurysm and thrombosis.” Therapeutic advances in respiratory disease (2026). PMID: 42439589 ↗
L4Cited in: Diagnosis and Workup - [234]
Guan Y, Hong P, Xiao R et al.. “Perioperative safety and short-term survival outcomes of radical nephrectomy with thrombectomy in geriatric renal cell carcinoma patients with venous tumor thrombus.” Minerva urology and nephrology (2026). PMID: 42438981 ↗
L3bCited in: Diagnosis and Workup - [235]
Sun Z, Li J, Zhao P et al.. “Risk Factors for Early Deep Vein Thrombosis After Free-Flap Reconstruction for Head and Neck Cancer Despite Routine Heparin Prophylaxis.” Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons (2026). PMID: 42425495 ↗
L3bCited in: Diagnosis and Workup - [236]
Wang N, Zhang Y, Zhang W et al.. “Association of Intramuscular Fat Infiltration With Incident Venous Thromboembolism: A Population-Based Cohort Study.” Journal of cachexia, sarcopenia and muscle (2026). PMID: 42422920 ↗
L3bCited in: Diagnosis and Workup - [237]
Ellison AM, Kuppermann N, Shihabuddin BS et al.. “PERC-Peds rule for bedside exclusion of pulmonary embolism without radiation in children in the USA (BEEPER): a multicentre, prospective, observational, diagnostic accuracy study.” The Lancet. Respiratory medicine (2026). PMID: 42398511 ↗
L3bCited in: Diagnosis and Workup - [238]
Huang J, Liu FC, Li L et al.. “Efficacy of combined modality conversion therapy for HCC with portal vein tumor thrombus: a retrospective cohort study.” Frontiers in immunology (2026). PMID: 42396444 ↗
L3bCited in: Diagnosis and Workup - [239]
Zhang S, Zhou J, Han Y et al.. “A Web-Based Machine Learning Calculator for Predicting Preoperative Deep Vein Thrombosis in Elderly Hip Fractures Patients.” Clinical interventions in aging (2026). PMID: 42376184 ↗
L3bCited in: Diagnosis and Workup - [240]
Akimoto K, Ikeda Y, Nakajima F et al.. “Incidence of lower extremity deep vein thrombosis following arthroscopic rotator cuff repair.” Journal of shoulder and elbow surgery (2026). PMID: 42342102 ↗
L4Cited in: Diagnosis and Workup - [241]
Zhu K, Li H, Zhang H et al.. “Multimodal Deep Learning for Predicting Deep Vein Thrombosis Risk After Total Knee Arthroplasty: A Clinical Study.” Orthopaedic surgery (2026). PMID: 42304630 ↗
L3bCited in: Diagnosis and Workup - [242]
Meng Y, Zhang C, Fan Z et al.. “Risk factors for preoperative isolated calf muscle vein thrombosis in elderly patients with hip fracture and development of a predictive nomogram: a retrospective study.” BMC musculoskeletal disorders (2026). PMID: 42437913 ↗
L2bCited in: Diagnosis and Workup - [243]
Dahlan K, Oganov A, Fazio N et al.. “Timing of anti-VEGF therapy and postoperative macular edema after cataract surgery in eyes with retinal vein occlusion: a retrospective cohort study.” BMC ophthalmology (2026). PMID: 42380785 ↗
L4Cited in: Diagnosis and Workup - [244]
Wang X, Chen X, Mao J et al.. “A machine learning-based risk prediction model for Hospitalized patients with deep vein thrombosis.” PeerJ (2026). PMID: 42544207 ↗
L3bCited in: Diagnosis and Workup - [245]
Cohen C, Klaassen I, Zhang S et al.. “An International Survey on the Assessment of Screening and Treatment of Thrombosis Complications in Pediatrics (ASTRO-Kids): communication from the ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis and Hemostasis.” Journal of thrombosis and haemostasis : JTH (2026). PMID: 41833696 ↗
L1cCited in: Special Populations - [246]
Al-Rubaish S, Awad A, Mehros W et al.. “Efficacy and safety of apixaban versus enoxaparin in gynecologic oncology surgery: a systematic review and meta-analysis.” International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2026). PMID: 42284982 ↗
L1aCited in: Special Populations - [247]
de Sousa Bernardes L, de Oliveira Woehl L, de Oliveira JG et al.. “Assessment of venous thromboembolism in adult-type diffuse gliomas at a quaternary neuro-oncology center: a retrospective cross-sectional study and systematic review.” Neurosurgical review (2026). PMID: 42032381 ↗
L2aCited in: Special Populations - [248]
Liu W, Zhang K, Chen S et al.. “Hepatic arterial infusion chemotherapy plus tyrosine kinase inhibitors with or without PD-1 inhibitors for advanced hepatocellular carcinoma with VP4 portal vein tumor thrombosis: a retrospective cohort study.” Frontiers in immunology (2026). PMID: 42245629 ↗
L4Cited in: Special Populations - [249]
Suzuki K, Gunji T, Nagao R et al.. “Geriatric nutritional risk index for the prediction of venous thrombotic events in multiple myeloma.” International journal of clinical oncology (2026). PMID: 42262688 ↗
L3bCited in: Special Populations - [250]
Pham KT, Dagi AF, Ly CL. “National trends and safety of prophylactic lymphovenous bypass during axillary lymph node dissection: A decade-long analysis of 61,819 patients through the NSQIP database.” Journal of plastic, reconstructive & aesthetic surgery : JPRAS (2026). PMID: 42161165 ↗
L3bCited in: Special Populations - [251]
Wang Y, Lv D, Chen X et al.. “Real-World Evidence on Preoperative Targeted Therapy for Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus.” Clinical genitourinary cancer (2026). PMID: 41963238 ↗
L4Cited in: Special Populations - [252]
Indorewala Y, Prashar S, Lee P et al.. “Evaluating maternal mortality, risk factors, and emergency c-section timing in polytrauma pregnant patients.” The American journal of emergency medicine (2026). PMID: 41932264 ↗
L3bCited in: Special Populations - [253]
Borad A, Andersen M, Guffey D et al.. “The Impact of Anticoagulation in Patients With Isolated Cancer-Associated Splanchnic Vein Thrombosis: A Dual-Center Cohort Study.” American journal of hematology (2026). PMID: 41891315 ↗
L3bCited in: Special Populations - [254]
Nahshon C, Fahoum L, Schmidt M et al.. “Is pharmacologic thromboprophylaxis needed in robotic-assisted hysterectomy? A big data study.” Journal of robotic surgery (2026). PMID: 41803413 ↗
L3bCited in: Special Populations - [255]
Jeong H, Yue SC, Kaelber DC et al.. “Risks of Retinal Vascular Occlusions with the Systemic Use of Tyrosine Kinase Inhibitors.” Ophthalmology. Retina (2026). PMID: 41791651 ↗
L4Cited in: Special Populations